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Plants are capable of producing a wide variety of molecules, and these fall broadly into 
two categories: primary metabolites and specialised metabolites. Primary metabolites are 
critical for growth and survival. Specialised metabolites, which are present in some plant 
species but not others, do not have a role in the central metabolism of all plants. 
Specialised metabolites can play many roles to allow plants to fill specific ecological 
niches, such as chemical defence or attraction of pollinators. Specialised metabolites may 
also be useful to humans as drugs, flavours or fragrances.  
The research described in this thesis investigates the potential of applying microbial 
biosynthesis techniques to produce grapevine (Vitis vinifera) specialised metabolites. Two 
classes of specialised metabolites were focussed on: tartaric acid and its biosynthetic 
intermediates, and sesquiterpenoids. Tartaric acid accumulates in grape berries during 
development and is essential to the winemaking process as it lowers the pH of the wine 
must, preventing discolouration and microbial spoilage. Sesquiterpenoids are a large class 
of compounds, many of which have unique aromas, and some have been found to 
contribute significantly to the character of wine. 
Bioinformatics were used to identify candidate 2-keto-L-gulonate reductases that may be 
involved in the biosynthesis of tartaric acid. Two candidate enzymes were expressed and 
purified for in vitro characterisation. It was found that these candidates are capable of 
utilising 2-keto-L-gulonate as a substrate but do not produce L-idonate, the next step in 
the tartaric acid pathway. The candidate enzymes exhibited low-level, broad-spectrum 
reductase activity. A previously identified 2-keto-L-gulonate reductase was used in the 
development of an E. coli cell factory for the whole cell biocatalysis of 2-keto-L-gulonate to 
L-idonate.  
A yeast strain specially engineered to overproduce the sesquiterpene precursor farnesyl 
pyrophosphate (FPP) was used for the synthesis of a range of grapevine sesquiterpenoid 
compounds. Six grapevine sesquiterpene synthases were expressed by the engineered 
yeast strain alongside a promiscuous P450 monooxygenase to produce potential 
grapevine sesquiterpenoid products in vivo. The compounds were identified by gas-
chromatography-mass-spectrometry. A total of seventeen unique compounds were 
confidently identified, with a number of uncharacterised compounds also produced. 
These compounds were found to possess a variety of aromas, and some compounds have 
beneficial health effects, which may be relevant for wine making and marketing.  
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Finally, homology modelling and docking studies were used to compare three grapevine 
P450 monooxygenases and investigate the mechanism of the formation of the 
sesquiterpenoid (-)-rotundone, the pepper aroma compound found in some wines. 
Computational docking studies of (-)-rotundone inside the P450 binding sites suggests the 
oxidation of α-guaiene to (-)-rotundone is due to the unique shape of the binding site of V. 
vinifera Sesquiterpene Oxidase 2 (VvSTO2). Two other P450s, VvSTO4 and VvSTO6 are 
able to accept α-guaiene as a substrate but do not form rotundone, due to different 
positioning of α-guaiene within the P450 active sites.  
The investigation of these specialised metabolites may provide new insights into the 
biosynthesis of tartaric acid and sesquiterpenoids in grapevine, and assist in the 







I certify that this work contains no material which has been accepted for the award of any 
other degree or diploma in my name, in any university or other tertiary institution and, to 
the best of my knowledge and belief, contains no material previously published or written 
by another person, except where due reference has been made in the text. In addition, I 
certify that no part of this work will, in the future, be used in a submission in my name, for 
any other degree or diploma in any university or other tertiary institution without the 
prior approval of the University of Adelaide and where applicable, any partner institution 
responsible for the joint-award of this degree.  
I give permission for the digital version of my thesis to be made available on the web, via 
the University’s digital research repository, the Library Search and also through web 
search engines, unless permission has been granted by the University to restrict access for 
a period of time.  
I acknowledge the support I have received for my research through the provision of an 




_ ___       _23/01/2019__ 





First of all, thank you to my supervisor Associate Professor Christopher Ford and my co-
supervisor Dr John Bruning. Chris, thank you for your encouragement, advice, feedback, 
and for allowing me time and flexibility to explore this topic and make the project my 
own. John, thank you for making time to show me the hands-on side of protein 
purification. Thank you also to Associate Professor Stephen Bell for lending his expertise 
and guidance to the project. 
Thank you to members of the Wine Microbiology lab and the Bruning lab for welcoming 
me into your workspace and assisting me with any questions. Thanks in particular to 
Michelle Walker, who guided me through the wild world of yeast microbiology, and Nick 
van Holst Pellekaan, whose technical expertise and assistance was invaluable. Many 
thanks also to Tony Hall for running my GC-MS samples and for sharing his extensive 
knowledge with me. 
During my studies I was fortunate to have the opportunity to travel to Calgary, Canada 
and I must acknowledge the Australian Government’s Endeavour Leadership Program for 
providing me with funding and support for this incredible experience. Thank you to Dae-
Kyun Ro for welcoming me into your country and your laboratory, and to the members of 
the Ro lab for their support, advice and friendship, both within and outside of the lab.  
Finally, thank you to my family who have supported me through my years of study, my 
friends, and especially to my fiancé, Kieran. I could not have done it without you all.  
1 
 
Chapter 1 Introduction 
Specialised Metabolism in Plants 
Plants are capable of synthesising a wide range of chemical compounds for many 
purposes, from basic metabolism to growth and survival. Primary metabolites are defined 
as compounds synthesised by all or most plant species, and it is estimated that there are 
less than 10,000 primary metabolites (Pichersky & Lewinsohn 2011). Specialised 
metabolites are compounds present in some plant species but not others, and do not have 
a role in the central, primary metabolism of all plants. Specialised metabolites can play 
many roles to allow plants to fill specific ecological niches. Some act as chemical 
attractants for pollination, or as defence against other organisms (Pichersky & Lewinsohn 
2011). The number of specialised metabolites made by plant species has been estimated 
at approximately 200,000 (Dixon & Strack 2003). The functions of many specialised 
metabolites are yet to be discovered. 
Specialised metabolites can be useful to humans. For example, many active drug 
compounds are natural products or natural product derivatives (Cragg, Newman & 
Snader 1997). Specialised metabolites can also contribute to the flavour and aroma of 
food. The wine grape (Vitis vinifera) produces many specialised metabolites that confer its 
unique properties and potential for winemaking (Ali et al. 2010). Grapes produce a large 
number of terpene compounds, predominantly monoterpenes and sesquiterpenes (Drew 
et al. 2016). In particular, the sesquiterpenoid rotundone, found in some varieties of 
grapevine, most notably Shiraz/Syrah, has been shown to have a potent peppery aroma 
and is an important contributor to wine character (Wood et al. 2008). Another important 
contributor to the organoleptic properties of wine is tartaric acid. Although tartaric acid is 
widespread throughout the plant kingdom, it accumulates in only very few species, and 
thus its biosynthesis can be considered specialised metabolism.  
Tartaric acid in plants 
Tartaric acid (TA) is a four-carbon dicarboxylic acid. It has a first dissociation constant 
(pK1) of 2.98 and a second dissociation constant (pK2) of 4.34, making it comparatively 
more acidic than other common organic acids including citric acid, malic acid, and 




Table 1-1 Dissociation constants for tartaric, citric, malic and ascorbic acids 
Acid pK1 pK2 pK3 
Tartaric 2.98 4.34 N/A 
Citric 3.09 4.74 5.41 
Malic 3.40 5.05 N/A 
Ascorbic 4.17 11.57 N/A 
 
TA exists as three stereoisomers, namely L-(+)-tartaric acid, D-(-)-tartaric acid and meso-
tartaric acid (Figure 1-1). All three stereoisomers have been found in nature. L-TA is the 
most common form, found in members of the Vitaceae and Geraniaceae families (Stafford 
1959). D-TA has been found in Bauhinia reticulata, and as caeffic acid esters in 
Cichoriumintybus L., C. endivia L. and Lactuca sativa L. (Wagner, Yang & Loewus 1975). 
Meso-TA occurs in spinach (Spinacia oleracea) as an ester of paracoumaryl alcohol 
(Suzuki et al. 1970). While TA has been found in a large number of species, only members 
of the Vitaceae, Geraniaceae and Leguminosae plant families accumulate significant 
amounts (Stafford 1959).  These species accumulate only the L isomer of TA (Wagner, 
Yang & Loewus 1975).  
 
 
Figure 1-1 Tartaric acid exists as three stereoisomers: the optically active D and L forms and the optically 
inactive meso form 
TA can be used as a carbon source by some species of yeast and bacteria (Fonseca 1992; 
Klasen, Bringer-Meyer & Sahm 1992). L-(+)-TA is most widely accessible but a small 
number of microorganisms can utilise D-(-)-TA and meso-TA (Fonseca 1992; Gutnick et al. 
1969). However; only the biosynthetic pathway of L-(+)-TA has been investigated 
(Loewus 1999). Therefore, only L-(+)-TA will be discussed from here. 
Sesquiterpenoids in Plants 
Terpenes are one of the largest classes of plant natural products, comprising at least 
30,000 compounds, and are incredibly structurally diverse (Connolly & Hill 1984). 
Sesquiterpenoids are 15-carbon terpene derivatives, and have a wide scope of activities in 
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plants. Many act as semiochemicals for plant signalling or defence (Bohlmann & Keeling 
2008). Sesquiterpenoids are often important contributors to plant aroma and components 
of plant essential oils (Dudareva & Pichersky 2000). Sesquiterpenes may have acyclic, 
mono-, bi-, tri-, or tetracyclic structures. Thousands of sesquiterpenoids have been 
identified in plants, although not all have been structurally elucidated (Duhamel et al. 
2018). 
Rotundone in plants 
(-)-Rotundone (Figure 1-2) is a sesquiterpene derivative responsible for the peppery 
aroma in a number of herbs and other plants. Rotundone was first identified in the tubers 
of Cyperus rotundus (nutgrass) (Kapadia et al. 1967) but its potent aroma was not 
discovered until the 2000s (Wood et al. 2008). In high concentrations it has a harsh, 
vinegar-like odour, which becomes spicy and peppery on dilution. Rotundone is present 
in high levels in pepper (Piper nigrum) and nutgrass (C. rotundus), and is also present in 
marjoram (Origanum majorana), oregano (Origanum vulgare), basil (Ocimum basilicum), 
thyme (Thymus vulgaris), rosemary (Rosmarinus officinalis), saltbush (Atriplex cinerea) 
and geranium (Pelargonium alchemilloides) (Wood et al. 2008). Rotundone is responsible 
for the spicy, peppery aroma of some Shiraz wines (Davies et al. 2015). It has also been 
detected in other wine varieties including Mourvedre and Durif (Wood et al. 2008). 
 
Figure 1-2 (-)-Rotundone, a sesquiterpene with a potent peppery aroma 
 
Grape berry development 
Grapevine is a perennial plant that flowers and fruits during spring and summer and is 
dormant throughout winter. It takes a grapevine at least three years to reach full maturity 
and produce wine-quality grapes, after which it can remain productive for many decades. 
The annual growth cycle of the grapevine progresses from budding to formation of shoots, 
cap fall, flowering, fruit set, veraison, harvest and, finally, leaf fall and winter dormancy 
(Lorenz et al. 1995). Berry development occurs immediately after flowering. This process 
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is characterised by rapid cell division and growth during berry formation, then a lag phase 
of minimal growth, and another period of cell growth during berry ripening (Coombe 
1960). During the berry formation phase, TA and malic acid accumulate and are stored in 
the vacuole of pericarp cells (Ollat et al. 2002). Tartaric acid accumulation begins soon 
after anthesis (flowering) and is linked to rapid cell division. During ripening, TA content 
plateaus and concentration decreases slightly due to dilution (Saito & Kasai 1968). 
Experiments using radiolabelled carbon dioxide show TA synthesis is restricted to the 
early stages of ripening and is not degraded in the cell (Saito & Kasai 1968).  Organic acid 
levels peak 1-2 weeks before berries change colour, and at this time the levels of tartrate 
and malate in the berry are approximately equal (Kliewer, Howarth & Omori 1967).  
‘Veraison’ indicates initiation of berry ripening and is hallmarked by acquisition of colour 
(in red fruit varieties) and softening of berry tissue (Coombe 1960). Before veraison, most 
of the sugars supplied to the berry are catabolised to provide energy for the rapidly 
growing cells. After the onset of ripening, hexoses accumulate in pericarp cells at a high 
rate and the berry grows due to expansion of cell size and uptake of water. The rates of 
sugar and water accumulation are tightly linked (Ollat et al. 2002). During early veraison, 
malate is metabolised via the TCA cycle, so TA levels are higher than malic acid levels in 
ripe grapes (Kliewer, Howarth & Omori 1967; Sweetman et al. 2009). 
During veraison the berry also accumulates specialised metabolites including aromatic 
compounds and polyphenolics. Sesquiterpenes are synthesised in the berry exocarp (May, 
Lange & Wüst 2013). Sesquiterpene precursors are synthesised in both the plastids and 
the cytoplasm, and transported to the cytoplasm where they act as a substrate for 
cytoplasmic sesquiterpene synthases (Martin et al. 2012; May, Lange & Wüst 2013). The 
levels of most sesquiterpenes continuously increase during the intermediate ripening 
phase through to post-ripening (Zhang et al. 2016b). At full ripeness the majority of 
sesquiterpenes are found in the berry exocarp, with only minor amounts in the mesocarp 
(May, Lange & Wüst 2013).  
TA synthesis occurs in both leaf and berry tissue (Saito & Kasai 1968). In both leaf and 
berry, TA synthesis occurs rapidly during early stages of development and plateaus in 
mature tissue (Ruffner 1982). Early work suggested organic acids were synthesised in the 
leaf and transported to the fruit but there is little evidence to support this (Hale 1962). In 
fact, when radiolabelled TA was injected into leaf tissue, there was no detection of 
radioactivity in the stem or berry tissue, indicating that it is unlikely that TA is 
transported into the berry (Ruffner 1982). Work by Hale (1962) established the berry as 
an important site of TA synthesis. There are several lines of evidence that suggest TA 
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synthesis occurs in the cytoplasm. Firstly, the TA biosynthetic precursor, ascorbic acid, is 
found in relatively high concentrations in the cytoplasm (Davey et al. 2000). Secondly, L-
idonate dehydrogenase (IdnDH), which catalyses the rate limiting step of the primary TA 
biosynthetic pathway in grapes, is mainly located in the cytoplasm (Wen et al. 2010). TA 
and malate are stored in the vacuole, which is characterised by a pH below 3.0 in the pre-
veraison berry (Diakou et al. 1997; Moskowitz & Hrazdina 1981). TA and malate are 
transported into the vacuole via tonoplast vesicles and likely compete for the same 
transporter (Terrier et al. 1998). Within the vacuole, TA is stored as potassium and 
calcium salts and free acid (Iland & Coombe 1988). 
Levels of TA and salts may reach up to 10 mg per berry (Iland & Coombe 1988; Kliewer, 
Howarth & Omori 1967). TA is important during the winemaking process as it decreases 
the pH of the must, preventing microbial spoilage and discolouration (Kalathenos, 
Sutherland & Roberts 1995). Exogenous TA may be added to the wine must to raise 
titratable acidity and stabilise the wine during the fermentation and maturation 
processes. TA is the ideal compound to lower pH because it is not broken down during 
winemaking, unlike malic acid which is degraded to the weaker lactic acid by malo-lactic 
fermentation (Liu 2002). TA has a ‘zingy’ taste and is an important contributor to the 
palatability, flavour and mouthfeel of wine, while malic acid has an unpleasant, metallic 
taste (Plane, Mattick & Weirs 1980).  
Over 90 different sesquiterpenoids have been identified in grapes and wine products 
(Duhamel et al. 2018). These exist in varying quantities, ranging from trace amounts up to 
several micrograms per litre (Duhamel et al. 2018; Parker et al. 2007).  Concentrations of 
rotundone in Shiraz grapes can reach up to 5.44 μg/kg (Caputi et al. 2011). Rotundone 
concentration is variable between vintages and depends on a number of factors including 
temperature and soil properties (Scarlett, Bramley & Siebert 2014; Zhang et al. 2015). 
Rotundone yield during winemaking is relatively low, with approximately only 6% 
recovered in the bottled wine (Caputi et al. 2011). Rotundone concentration in Shiraz 
wine has been found in levels varying between 29 ng/L to 145 ng/L (Wood et al. 2008). 
While the concentration of rotundone in Shiraz is relatively low compared to other 
species that synthesise rotundone, it is an important contributor to wine character. 
Rotundone is extremely potent, with a threshold of detection as low as 8 ng/L in water 
and 16 ng/L in red wine (Wood et al. 2008). This gives the wine a ‘spicy’ or ‘peppery’ 
character.   
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Tartaric acid biosynthesis in Vitaceae 
Early efforts to elucidate the biosynthetic pathway of tartaric acid in grapes identified L-
ascorbic acid (Asc) as a precursor. Saito and Kasai (1969) fed young grape berries with 
radiolabelled L-ascorbic acid-1-14C for 24 hours and discovered 72% of the radioactivity 
was found in TA. Combined with previous results which showed radioactivity from Asc-6-
14C was not incorporated into TA (Loewus & Stafford 1958), this gave evidence that TA 
was formed from the C1-C4 moiety of Asc (Figure 1-3). To confirm this, immature grape 
berries and leaves were fed with L-ascorbic acid-4-14C. 60% of soluble 14C was found in 
TA, and of this virtually all of the 14C was present in the terminal carboxyl groups 
(Williams & Loewus 1978). This indicates that the C1-C4 moiety of Asc is directly 
converted into TA.  
 
Figure 1-3 L-ascorbic acid 
To investigate intermediates in the TA synthesis pathway, Saito and Kasai (1982) 
performed a time course experiment where slices of immature grape berry were fed with 
L-ascorbic acid-1-14C  and the metabolites analysed after 0-5 hours. Based on 14C 
incorporation, L-idonic acid, L-idono-γ-lactone and 2-keto-L-idonic acid (2-keto-L-gulonic 
acid) were identified as metabolic products of ascorbic acid, but there was insufficient 
evidence to conclude their position in the pathway from ascorbic acid to tartaric acid. A 
fourth, unknown compound, later identified as 5-keto-L-idonic acid (5-keto-D-gluconic 
acid), was also observed to contain 14C before the accumulation of labelled tartaric acid. 
Subsequent experiments by Saito and Kasai (1984) introduced specifically labelled L-
idonic acid, L-idono-γ-lactone, 2-keto-L-gulonic acid (2KLG) and 5-keto-D-gluconic acid 
(5KDG) into grape slices and tissue to analyse the incorporation of 14C into tartaric acid 
and the involvement of each metabolite in the tartaric acid biosynthesis pathway. Based 
on the incorporation of a large amount of label (86-90%) from the substrates into tartaric 
acid, Saito and Kasai (1984) proposed a pathway from ascorbic acid to 2KLG, then L-
idonic acid, then 5KDG and, via unknown intermediate(s), to tartaric acid. This pathway 
was supported by further studies (DeBolt, Cook & Ford 2006; Malipiero, Ruffner & Rast 
1987). Incorporation of radiolabel from 5-keto-1-14C-gluconic acid but not from 5-keto-6-
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14C-gluconic acid indicated a C4/C5 cleavage of 5-keto-D-gluconic acid. The four-carbon 
product of this cleavage is L-threo-tetruronate (tartaric acid semialdehyde) which is 
oxidised to tartaric acid (Saito 1992). The two carbon product is likely glycolaldehyde, 
which is recycled back into the hexose pool (Saito & Loewus 1979). Kinetic studies 
suggest the rate limiting step of the pathway is the oxidation of L-idonate to 5KDG 
(Malipiero, Ruffner & Rast 1987) (Figure 1-4).  
 
Figure 1-4 The primary pathway of tartaric acid biosynthesis in Vitaceae 
As well as the primary pathway of TA biosynthesis from an Asc precursor, a secondary 
pathway from D-gluconic acid is also present in Vitaceae. The primary pathway accounts 
for up to 99% of TA synthesis in the light, and between 68-74% of TA synthesis in the 
dark (Saito & Loewus 1989). The secondary pathway utilises the C1-C4 backbone of 6-
carbon glucose and proceeds via D-gluconate to 5KDG and follows the subsequent 
pathway shown in Figure 1-4 (Saito & Loewus 1989).  
L-Ascorbic acid can also act as a precursor for oxalic acid. When grape berries were fed 
with L-ascorbic acid-1-14C, 21% of radiolabel was observed in oxalic acid, and 53% of 
radiolabel was found in tartaric acid (DeBolt et al. 2004). This indicates both C2/C3 
cleavage and C4/C5 cleavage of ascorbic acid occurs in grapevine.   
Enzymes involved in the biosynthesis of Tartaric Acid in Vitaceae 
The stereospecificity of the metabolic intermediates suggests each step is likely to be 
enzyme catalysed. Selective oxidation of 5KDG to L-TA can occur in acidic and alkaline 
conditions with a vanadate catalyst (Matzerath et al. 1995), but 18O labelling experiments 
suggest the C4/C5 cleavage of 5KDG is likely to be catalysed by a hydrolase (Saito, 
Ohmoto & Kuriha 1997). Furthermore, TA is produced as a by-product of 5KDG 
fermentation in E.coli in the absence of vanadium, so this conversion is likely to be 
enzyme-catalysed (Salusjärvi et al. 2004). Several E. coli transketolases and commercial 
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yeast transketolases accept 5KDG as a substrate. Salusjärvi et al. (2004) propose 5KDG is 
cleaved by a ketolase to TA semialdehyde which is oxidised by a dehydrogenase. This 
mechanism is consistent with the observation that 18O is incorporated into TA from water 
(Saito, Ohmoto & Kuriha 1997), but the corresponding enzymes in E. coli have not been 
identified. Nevertheless, this evidence supports enzyme catalysis of each step in the TA 
synthesis pathway in grapevine.  
To date, very few of the enzymes in the pathway have been identified. An L-idonate 
dehydrogenase (L-IdnDH) gene was identified by comparing the transcript abundance of 
TA biosynthesis candidate genes in TA accumulating and non-accumulating species 
respectively. The L-IdnDH gene was not present in a non-TA-accumulating species, but 
was expressed in TA-accumulating grape species, and its gene expression pattern was 
consistent with TA synthesis in developing berries (DeBolt, Cook & Ford 2006). The 
candidate gene was found to share 31% amino acid identity with an E. coli oxidoreductase 
that catalyses the interconversion of L-idonate and 5-keto-D-gluconate. In vitro assays 
confirmed the enzyme was able to specifically catalyse the interconversion of L-idonate 
and 5-keto-gluconate using NAD+/NADH as a cofactor (step 3 in Figure 1-4). Kinetic 
analysis gave a Km of 2.2 mM for L-idonate in the forwards reaction, and 12.5 mM for 
5KDG in the reverse direction. This provides in vitro and, through analysis of a non-
tartaric acid accumulating species, in vivo evidence the L-IdnDH catalyses the rate-limiting 
step of tartaric acid biosynthesis (DeBolt, Cook & Ford 2006). Subcellular localisation 
studies using antibodies against L-IdnDH showed L-IdnDH is located mainly in the 
cytoplasm,  with a small portion in the cell wall, secondary cell wall and chloroplasts in 
developing berries (21 days after full bloom) (Wen et al. 2010). After 60 days, L-IdnDH 
localises to the cytoplasm and vacuole, which suggests tartaric acid synthesis occurs in 
the cytoplasm, and possibly the vacuole, although vacuolar localisation may be due to 
protein degradation (Wen et al. 2010). Further work has supported the role of L-IdnDH in 
tartaric acid synthesis. CRISPR/Cas9-mediated disruption of an L-IdnDH gene in 
Chardonnay led to a decrease in TA content of the transgenic cell mass (Ren et al. 2016). 
Sequencing of the grapevine genome led to the identification of a further three isoforms of 
L-IdnDH, one of which is likely to be a sorbitol dehydrogenase (Jia et al. 2015). Therefore, 
there may be several, closely related, isoforms of each enzyme involved in TA synthesis.  
Since the sequencing of the grape genome, further bioinformatic approaches have been 
utilised to identify putative enzymes in the tartaric acid synthesis pathway. Burbidge 
(2011) found a number of 2KLG reductase candidates through a sequence homology 
search with an Escherichia coli enzyme capable of catalysing 2KLG to L-idonate (Yum et al. 
9 
 
1998). Three candidates were expressed for further analysis and one of these was found 
to have activity against 2KLG with NADH and NADPH, with a Km of 4.7 mM for 2KLG using 
NADH as the cofactor. Although activity was highest against 2KLG, activity was also 
observed with D-gluconate and L-ascorbate substrates, although to a lower extent 
(Burbidge 2011). While there is evidence to support the annotation of this enzyme as a 
2KLG reductase, the Km of this enzyme is fairly high, which is inconsistent with the low 
levels of TA biosynthetic intermediates present in immature grapes (Saito & Loewus 
1979). Further evidence, including in planta experiments, is required to confirm its role in 
TA synthesis.  
A limiting factor in the study of tartaric acid biosynthesis is the limited commercial 
availability of L-idonate. Cheap and efficient production of L-idonate would greatly benefit 
further research in this field.  
Fungal 2-keto-L-gulonate reductases 
Comparison between grapevine enzymes and enzymes from other species with known 
activity can help identify potential catalysts in the TA biosynthesis pathway. Recently, two 
fungal 2-keto-L-gulonate reductases (2KGR) capable of interconverting 2KLG and L-
idonate (step 2 in Figure 1-4) were identified in Aspergillus niger (Kuivanen, Arvas & 
Richard 2017; Kuivanen et al. 2016). These 2KGRs are involved in the catabolism of D-
glucuronate and show unique enzyme activity. Previously, Yum et al. (1998) identified an 
E. coli 2-ketoaldonate reductase with low specificity that can also catalyse the conversion 
of 2KLG to IA, but these fungal enzymes are the first substrate specific 2KGRs to be 
reported. The GluC protein uses NAD+/NADH as a cofactor and has a Km of 30 mM and 20 
mM respectively for 2KLG and L-idonate (Kuivanen et al. 2016). The GluD protein uses 
NADP+/NADPH as a cofactor with a Km 25.3 and 12.6 mM for 2KLG and L-idonate 
respectively (Kuivanen, Arvas & Richard 2017). The amino acid sequences of these 2KGRs 
can be compared to proteins present in grapevine using a Basic Local Alignment Search 
Tool (BLAST). Grapevine enzymes with high similarity, as well as similar conserved 
domains and cofactor binding sites, are likely to have the same 2KGR activity.  
Sesquiterpene biosynthesis in Vitaceae 
All terpenes are synthesised from 5-carbon building blocks of isopentenyl pyrophosphate 
(IPP) and dimethylallyl pyrophosphate (DMAPP) (Eisenreich et al. 2004). IPP and DMAPP 
can be synthesised by two separate pathways in plants (Figure 1-5). The mevalonate 
pathway is common to all eukarya, and also present in archaea and some bacteria, and 
occurs in the cytoplasm (Eisenreich et al. 2004). The non-mevalonate pathway, or MEP 
pathway is present only in plants, bacteria and some archaea. In plants, this pathway 
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occurs in the plastids (Eisenreich et al. 2004). Radiolabelling studies have shown that 
both pathways contribute to sesquiterpene synthesis in grapevine, indicating transport of 
IPP/DMAPP from plastid to cytosol (May, Lange & Wüst 2013). In the cytosol, two IPP 
units and one DMAPP unit combine to form the 15-carbon sesquiterpene precursor 
farnesyl pyrophosphate (FPP). The sesquiterpene backbone is created through 
modification of FPP by sesquiterpene synthases (STS). The sesquiterpene can be further 
functionalised or modified to a sesquiterpenoid by regio- and stereo-selective cytochrome 
P450 monooxygenases (CYPs) or various transferases (Nguyen, MacNevin & Ro 2012; 
O'Maille et al. 2008). 
Rotundone is synthesised via a sesquiterpene synthase that converts FPP to α-guaiene in 
a single step, followed by CYP oxidation at C2 (Figure 1-5) (Drew et al. 2016; Kumeta & Ito 
2010; Takase et al. 2016). The grapevine sesquiterpene synthase that converts FPP to α-
guaiene, VvGuaS, was identified as an allelic variant of the VvTPS24 which encodes 
VvPNSeInt, a selinene-type sesquiterpenes synthase (Drew et al. 2016). Two key 
polymorphisms close to the active site were implicated in the difference in products 
between the two enzymes. The products of the VvGuaS enzyme are α-guaiene (44%), δ-
guaiene 35% and a number of minor products (Drew et al. 2016). α-Guaiene is oxidised at 
the C2 position by VvSTO2, an α-guaiene 2-oxidase, which is a cytochrome P450 in the 
CYP71BE subfamily (Takase et al. 2016). VvSTO2 is highly specific for α-guaiene and (+)-
valencene, although the latter is not present in grapevine in significant levels, so VvSTO2 
acts solely as an α-guaiene oxidase in grapevine (Takase et al. 2016). The major product of 
VvSTO2 is rotundone, with two minor products which are probably 2R- and 2S-rotundol, 
likely intermediates in the oxidation of α-guaiene to rotundol (Takase et al. 2016). Auto-
oxidation of α-guaiene to rotundone has also been shown to occur spontaneously in air 
over a number of days to weeks (Huang et al. 2014). This demonstrates that exposure to 
air during winemaking may also play a role in rotundone synthesis. Therefore, rotundone 




Figure 1-5 Rotundone synthesis in Vitaceae. Adapted from Martin et al. (2012). The following metabolites are 
shown: G3P glyceraldehyde 3-phosphate, DOXP  1-Deoxy-D-xylulose 5-phosphate, MEP 2-C-methyl-D-erythritol 4-
phosphate, HMB-PP (E)-4-hydroxy-3-methyl-but- 2-enyl pyrophosphate, IPP isopentenyl pyrophosphate, DMAPP 
dimethylallyl pyrophosphate, MVPP mevalonate-5-pyrophosphate, FPP farnesyl pyrophosphate 
Microbial Biosynthesis 
Microbial biosynthesis is an efficient and versatile method of obtaining useful products. It 
has many advantages over traditional chemical synthesis. Firstly, microbial biosynthesis 
circumvents the need for toxic organic solvents and heavy metals, reducing the 
environmental impact of synthesis. Secondly, synthesis is usually high-yielding as it is 
stereoselective and avoids the formation of by-products (Du, Shao & Zhao 2011). Finally, 
synthesis can be achieved from cheap feedstocks such as glucose, glycerol, or xylose 
(Markham & Alper 2015; Mazumdar, Clomburg & Gonzalez 2010). Microbial synthesis has 
been used in the production of a wide range of useful chemicals including 
pharmaceuticals, biofuels, polymers, and vitamins (Abdel-Rahman et al. 2011; Bremus et 
al. 2006; Buchholz & Seibel 2008; Jeandet et al. 2013). 
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There are three main categories of microbial biosynthesis: fermentation, bioconversion 
with purified enzymes, and whole-cell biocatalysis. Fermentation requires the 
engineering of metabolic pathways to produce the desired product from a cheap, readily 
available feedstock. Fermentation generally requires low-cost raw materials, but may be 
low-yielding. Additionally, since growth rate is affected by product synthesis, costly 
supplementation may be required (Bückle-Vallant et al. 2014). Alternatively, 
bioconversion from substrate to product can be achieved by purified soluble or 
immobilised enzymes. Generally yields are higher and purification is easier, especially 
with immobilised enzymes. However, enzymatic bioconversion is expensive due to the 
cost of protein purification and immobilisation, and the need to supply cofactors (Song et 
al. 2016). Furthermore, the price is dependent on the cost of the substrate. Whole-cell 
biocatalysis is a third option that uses metabolically dormant cells containing the desired 
enzyme activity. This method is estimated to be ten times cheaper than using purified 
enzyme catalysts (Tufvesson et al. 2011). Another advantage is that cofactors are supplied 
by the cell and can, to some extent, be regenerated by existing cellular mechanisms. If 
supplementary cofactor regeneration is required it is usually straightforward to 
implement (Wachtmeister & Rother 2016). The cellular structure also provides protection 
for the catalysts, allowing harsher conditions and non-aqueous media to be used in order 
to maximise product yield. While the cost is still dependent on the price of the substrate, 
whole-cell biocatalysis is generally an efficient and inexpensive method of producing 
target metabolites.  
Microbial biosynthesis can be used to achieve efficient stereoselective synthesis of 
compounds. Fermentation has been used to produce L-(+)-lactic acid with a greater than 
99.5% enantiomeric excess from xylose, an abundant sugar (Abdel-Rahman et al. 2011). 
Maintenance of stereochemistry is one of the biggest challenges in the chemical synthesis 
of L-idonate and sesquiterpenes due to their high number of stereocentres. Additionally, 
the separation of the product from a mixture of enantiomers poses further challenges. 
Using a biosynthetic tactic to produce L-idonate and rotundone with high optical purity 
will avoid this problem.  
Microbial Biosynthesis of Keto Acids  
While the microbial synthesis of L-idonate is novel, the technique has been used to 
produce related compounds. As well as being an intermediate in the TA biosynthesis 
pathway in grapevine, 2KLG is also a precursor for the commercial synthesis of ascorbic 
acid. 2KLG has been produced by fermentation from glucose in Erwinia citreus with a 
conversion efficiency of 49.4% (Grindley et al. 1988). E. citreus is naturally able to oxidise 
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D-glucose to 2,5-diketo-D-gluconate (2,5-DKG) via D-gluconate and 2-keto-D-gluconate. 
By expressing a gene for a 2,5-DKG reductase from Corynebacterium sp. in E. citreus, the 
organism was able to produce 2KLG from glucose. Yields were improved for selecting for 
mutants that were not able to utilise 2,5-DKG or 2KLG as a sole carbon source (Grindley et 
al. 1988). More recently, 2KLG production from 2,5-DKG has been achieved by coupling 
2,5-DKG reductase to a NADPH-regenerating glucose dehydrogenase (Kaswurm et al. 
2013). Modelling was used to optimise process parameters and double the yield of 2KLG 
(Kaswurm et al. 2013). This is an example of in situ cofactor regeneration using glucose as 
a sacrificial substrate. It also demonstrates the usefulness of mathematical modelling as a 
tool for designing bio-catalytic systems. Many other keto acids, including α-ketoglutarate 
and 2,5-DKG, have been produced by microbial biosynthesis, sometimes with yields over 
90% (Song et al. 2016). Therefore, microbial biosynthesis represents a viable method of 
producing L-idonate cheaply and efficiently. Whole-cell biocatalysis is ideal because 
several 2KLG reductases have already been identified (Burbidge 2011; Kuivanen, Arvas & 
Richard 2017; Kuivanen et al. 2016; Yum et al. 1998) and the substrate, 2KLG, is 
inexpensive in bulk quantities.  
The 2KGRs that catalyse the interconversion of 2KLG and L-idonate utilise either NADH or 
NADPH as a cofactor. The cofactor is required in stoichiometric quantities, so in situ 
regeneration of NAD(P)+ to NAD(P)H is preferable to adding large amounts of cofactor. 
Several regeneration methods are possible. Electrochemical regeneration using a cathode 
is environmentally friendly because no co-substrate is required and no by-products are 
produced, but requires specialist equipment, and current technology is not efficient 
enough to be economically feasible (Kara, Schrittwieser & Hollmann 2013). The use of H2 
as a reducing agent, catalysed by hydrogenases has been explored but is limited by the 
oxygen-sensitivity of hydrogenase enzymes and poor water solubility of H2 (Kara, 
Schrittwieser & Hollmann 2013). The use of a sacrificial co-substrate is the most widely 
used method. This requires a catalyst to oxidise the co-substrate which produces a by-
product that must be separated from the reaction mixture. Common co-substrates include 
formates, phosphites, alcohols and glucose, with a corresponding dehydrogenase to 
catalyse their oxidation (Kara, Schrittwieser & Hollmann 2013). The choice of co-
substrate depends on the cofactor required (NADH or NADPH) and the selectivity of the 
reductase. It is important that the co-substrate cannot act as a substrate for the reductase 
that produces the target product as this would decrease the yield and efficiency of the 
process.   
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Microbial Biosynthesis of Sesquiterpenes 
Starting materials for sesquiterpene synthesis such as FPP are often expensive, making 
bioconversion uneconomical. Instead, a strain of yeast (Saccharomyces cerevisiae EPY300) 
that produces a high level of FPP was engineered for the fermentation of sesquiterpenes 
from a simple sugar feedstock (Ro et al. 2006). Sesquiterpene biosynthesis can be 
achieved by expression of at least one sesquiterpene synthase (STS) and, optionally, a 
sesquiterpene-modifying P450.  
An example of the use of this yeast strain is for the production of capsidiol, a hydroxylated 
sesquiterpenoid that is an important plant defence molecule. EPY300 was transformed 
with a pESC-Leu2d plasmid containing a 5-epi-aristolochene STS with a 5-epi-
aristolochene-hydroxylating P450 and its corresponding redox partner. The yeast was 
cultured on media containing galactose and methionine. The strain is engineered so that 
in the presence of galactose and methionine, the mevalonate pathway is upregulated and 
FPP production increases. Capsidiol production was analysed by GC-MS, with a yield of 
approximately 250 μg/mL (Nguyen, MacNevin & Ro 2012).  
Grapevine sesquiterpenoids may be produced in a similar way. By expressing grapevine 
sesquiterpene synthases with a promiscuous P450 in EPY300 yeast, sesquiterpenoid 
synthesis could be achieved from a glucose/galactose feedstock.  
Research Objectives 
Tartaric acid is an important chemical in the winemaking process as it prevents microbial 
spoilage and oxidation during fermentation and contributes to the organoleptic 
properties of the wine. However, its biosynthesis is poorly understood. Research 
undertaken for this project will identify genes that may be involved in the TA biosynthesis 
pathway in grapevine.  
Sesquiterpenes are important contributors to the flavour and aroma of wine. In particular, 
rotundone is a key aromatic compound in Shiraz wine and has been shown to have a 
significant effect on wine character. This project will characterise enzymes involved in the 
synthesis of sesquiterpenoids, including rotundone, and establish methods to synthesise 
these compounds cheaply and efficiently. 
The specific aims of this study are to: 
 Identify putative 2-keto-L-gulonate reductase enzymes involved in the TA 
biosynthesis pathway in grapevine 
 Characterise the substrate specificity and enzyme kinetics of the above candidates 
15 
 
 Develop a microbial biosynthesis system capable of producing L-idonate from 2-keto-
L-gulonate 
 Develop a microbial biosynthesis system capable of producing grapevine 
sesquiterpenoids from simple sugar feedstocks 
 Develop a microbial biosynthesis system to investigate the mechanism of rotundone 
formation 
This will lead to an overall better understanding of how organic acids and aromatic 
molecules are synthesised in grapes. Potentially this will allow grape breeders in the 
future to better control and select for tartaric acid or rotundone production in grapevine 




Chapter 2 Methods 
Materials, Chemicals and Equipment 
Substrates, reagents, growth media and buffers 
Substrates, reagents and solvents were supplied by Sigma-Aldrich (USA), Bio-Rad (USA) 
or Roche (Germany) as required. 2-Keto-L-gulonate was purchased from Sigma-Aldrich 
and L-Idonate was purchased from Omicron Biochemicals. All media and buffers used are 
listed in Table 2-1 and Table 2-2 respectively. Antibiotics were added to LB as required. 
Ampicillin was added to a concentration of 100 mg μL-1. Liquid media was sterilised by 
filtration or autoclaving. Solid media was prepared by the addition of 2% bacteriological 
agar and sterilised by autoclaving. 
Table 2-1 Growth media components 
Medium Components (L-1) 
LB  tryptone (10 g), yeast extract (5 g), NaCl (5 g) 
SOC tryptone (20 g), yeast extract (5 g), MgCl2 (1 g), NaCl (0.5 g), KCl (0.2 
g), glucose (2 g) 
YPD glucose (20 g), yeast extract (10 g), bacto peptone (20 g) 
SC Yeast Nitrogen Base without amino acids (1.7 g), ammonium sulfate 
(5 g), adenine (21 mg), 16 standard amino acids (without histidine, 
leucine, methionine and tryptophan) (85.6 mg each), leucine (173.4 
mg), histidine (85.6 mg), methionine (85.6 mg), tryptophan (85.6 mg), 






Table 2-2 Buffer components 
Buffer Components  
Buffer A Tris 8.0 (20 mM), NaCl (0.5 M), 2-mercaptoethanol (BME) (2 
mM), imidazole (10 mM) 
Buffer B Tris 8.0 (20 mM), NaCl (0.5 M), BME (2 mM), imidazole (250 
mM) 
Dialysis Buffer Tris 8.0 (20 mM), NaCl (50 mM), BME (2 mM), Dithiothreitol 
(DTT) 1mM 
Tris Buffer Tris(hydroxymethyl)aminomethane 50 mM  
(pH adjusted by addition of HCl) 
TE Buffer pH 8.0 Tris 10 mM, Ethylenediaminetetraacetic acid (EDTA) 1mM (pH 
adjusted by addition of HCl) 
PBS pH 7.4 NaCl (137 mM), KCl (2.7 mM), Na2HPO4 (10 mM), KH2PO4 (1.8 
mM) 
HEPES Buffer HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
100 mM (pH adjusted by addition of NaOH) 
SDS Loading 
Buffer 
Tris pH 6.5 (100 mM), sodium dodecyl sulphate (SDS) (4% v/v), 




High Performance Liquid Chromatography (HPLC) was performed on an Agilent 1100 
series pump equipped with an auto injector connected to a Phenomenex ROA-Organic 
Acid Column (300 x 7.8 mm). 
Gas Chromatography-Mass Spectrometry (GC-MS) for sesquiterpenoid analysis was 
performed on an Agilent 7890B GC using a 5977B MS detector and a DB-5 MS fused silica 
column (30 m x 0.25 mm, 0.25 µm).  
GC-MS analysis for α-guaiene analysis was performed on an Agilent 6890 using an Agilent 
5973 N mass spectrometer and a DB-5 MS fused silica column (30 m x 0.25 mm, 0.25 µm). 
 
Bioinformatics 
The genome sequences for Vitis vinifera were accessed from the National Center for 
Biotechnology Information (NCBI) database. Using this database, candidates were 
identified by protein Basic Local Alignment Search Tools (BLAST) 
(https://blast.ncbi.nlm.nih.gov/). Protein sequence analysis and classification was 
performed using InterPro (https://www.ebi.ac.uk/interpro/). Expression patterns were 
analysed using Expression Atlas (https://www.ebi.ac.uk/gxa/home).  Subcellular 
localisation and transmembrane structure analysis was performed using CBS Prediction 
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Services (http://www.cbs.dtu.dk/services/). Local secondary structure prediction was 
performed using Spider 2 (http://sparks-lab.org/server/SPIDER2/).  
Enzyme Expression, Purification and Characterisation  
Plasmids and Strains 
E. coli strain DH5α (New England Biolabs) was used for cloning and plasmid construction. 
Plasmids used in this study are listed in Table 2-3. Putative 2KGR genes were codon-
optimised for E. coli, synthesised and cloned into pET-11a vectors using NdeI and BamHI 
restriction sites by GenScript (US). For Gateway® cloning, the 2KGR genes were PCR 
amplified using the primers in Table 2-4. PCR was performed in a 50 μL reaction with 2 
units VELOCITY DNA Polymerase (Bioline), 1 x HiFi Reaction Buffer (Bioline), 10 mM 
dNTP, 10 μM forward and reverse primers, and 2 ng template plasmid. PCR was 
performed on a BioRad T100 thermal cycler with a standard cycle of: 98 °C for 2 minutes, 
30 cycles of 98 °C for 30 seconds, 55 °C for 30 seconds and 72 °C for 35 seconds, followed 
by a final extension at 72 °C for 4 minutes. PCR products were visualised with gel 
electrophoresis. The donor vector was pDONR221 and the destination vector was 
pDEST57. For the BP reaction, a 5 μL reaction consisting of 50 ng PCR product, 500 ng 
donor vector, 2 μL TE buffer pH 8.0 and 1x BP Clonase Enzyme Mix (Invitrogen) was 
incubated at room temperature for 2 hours followed by incubation with 0.5 μL Protein 
Kinase K (Invitrogen) at 37 °C for 10 minutes. For the LR reaction, a 5 μL reaction mixture 
containing 100 ng each of donor and destination vector, 2 μL TE buffer and 1x LR Clonase 
Enzyme Mix (Invitrogen) was incubated at 25 °C for 1.5 hours followed by incubation 
with 1 μL Protein Kinase K (Invitrogen) at 37 °C for 10 minutes.  
Table 2-3 Plasmids used for protein expression and purification 
Plasmid Description Source 
pET-11a Expression vector, AmpR, PT7, 3851 ori Novagen 
pET-14b Expression vector, AmpR, PT7, 2845 ori Novagen 
pDONR-221 Gateway® donor vector, KanR, PT7, pUC ori Novagen 
pDEST-57 Gateway® destination vector for expressing 
proteins tagged at the N-terminus with NusA, AmpR, 
PT7, pBR322 ori 
Novagen 
pET-11a-2KGR.1 Candidate XP_002284520.1 inserted into 
NdeI/BamHI sites of pET-11a 
This study 
pET-11a-2KGR.2 Candidate XP_002281980.1 inserted into 
NdeI/BamHI sites of pET-11a 
This study 
pDEST-57-2KGR.1 Candidate XP_002284520.1 inserted into attR sites 
of pDEST-57 
This study 












Table 2-4 Primers used for Gateway® Cloning 
Primer Sequence 
Candidate 1 F GGGGACAAGTTTGTACAAAAAAGCAGGCTY 
YGAAAACCTGTATTTTCAGGGAATGGAAAA 
CATCTGTGTCTTATTGAC 
Candidate 1 R GGGGACCACTTTGTACAAGAAAGCTGGGTY 
TTAAATTACTGGTGTTAACACGGGT 
Candidate 2 F GGGGACAAGTTTGTACAAAAAAGCAGGCTY 
YGAAAACCTGTATTTTCAGGGAATGACTGC TATGGATGAGTTGC 
Candidate 2 R GGGGACCACTTTGTACAAGAAAGCTGGGTY 
TTAGTCAAGATTAATGGGACTAAGTAATG 
 
Sequencing was performed by the Australian Genome Research Facility. Purified DNA and 
primers were supplied according to AGRF guidelines.  
E. coli strain BL21 (DE3) (New England Biolabs) was used for all protein expression and 
feeding experiments. 
Transformation 
E. coli strains DH5α and BL21 (DE3) were transformed according to the following 
protocol. Approximately 50 ng plasmid DNA was added to 50 μL competent cells. After 30 
minutes on ice, the cells were heat-shocked at 42 °C for 10 seconds and placed back on ice 
for 5 minutes. Sterile SOC medium (300 μL) was added and the cells incubated at 37 °C 
with shaking for 1 hour. The cells were then plated on LB agar with appropriate antibiotic 
and incubated at 37 °C overnight. 
Protein Expression and Purification 
BL21(DE3) was transformed with pDONR57 derived vectors. Single colonies were picked 
and inoculated in 50 mL LB at 37°C overnight on a rotary shaker. 20 mL of pre-inoculum 
was transferred to 4 L LB and grown in a baffled flask at 37°C until the OD600 reached 0.6-
0.8. Protein expression was induced by the addition of 0.5 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) and cultures incubated at 16 °C overnight. Cells were 
harvested by centrifugation (5000 x g, 20 minutes) and lysed using a French press. The 
lysis solution was centrifuged at 4 °C 10,000 x g for 60 minutes. The supernatant was 
loaded onto a BioScale Mini Profinity IMAC 5 mL Cartridge (BioRad) using a LKB pump 
(Pharmacia). The protein was eluted into 45 mL Buffer B and dialysed at 4 °C overnight in 
Dialysis Buffer. The enzyme solution was flash-frozen with liquid nitrogen and stored at -
80 °C for enzyme assays. 
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Protein purity was confirmed by visualisation using Sodium Dodecyl Sulphate 
Polyacrylamide Gel Electrophoresis (SDS-PAGE). 10 μL samples were added to SDS 
loading buffer and boiled for 5 minutes. Samples were then loaded onto SurePAGE Bis-
Tris 10 x 8 (GenScript) gels in Tris-MOPS-SDS running buffer (GenScript) and 
electrophoresed for 30 minutes at 200 V. Gels were stained for 10 minutes using 
Coomassie blue stain (Coomassie blue stain (40% (v/v) ethanol, 7% glacial acetic acid, 
0.1% (w/v) Coomassie blue). Excess Coomassie blue stain was removed and gels were 
immersed in Coomassie destain (10% (v/v) glacial acetic acid, 40% methanol (v/v)) 
overnight.  
Proteins were quantified as required using a NanoDrop 2000 spectrophotometer 
(Thermo Scientific, USA) using an extinction coefficient of 45000 cm-1 M-1. 
In vitro Enzyme Assays 
Enzyme activity was analysed by monitoring the oxidation or reduction of the cofactor 
NADH at 340 nm using a 96-well plate (Costar) with a FLUOStar OPTIMA plate reader 
(BMG Labtech). Activity was tested over varying pH using both HEPES and Tris-HCl 
buffers (100 mM) to ensure changes in activity were due to pH and not buffer 
composition. A typical reaction consisted of 186 μL buffer, 2 μL enzyme (0.5 μg final), 2 μL 
coenzyme solution (0.25 mM final). The reaction was initiated by addition of 10 μL 
substrate solution to a total reaction volume of 200 μL. The reaction was monitored for 40 
minutes at 37 °C with absorbance readings taken every 90 seconds. Negative controls 
included no enzyme, no substrate and no cofactor controls. Data was analysed using 
GraphPad Prism version 8.0.0. 






=  𝜇𝑚𝑜𝑙𝑒𝑠/𝑚𝑖𝑛/𝑚𝑔 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 
Where l is the path length and ε is the extinction coefficient of NADH. The extinction 
coefficient of NADH used was 6200 L mol-1 cm-1 at 340 nm.  
Whole Cell Biocatalysis 
Whole cell biocatalysis experiments were conducted using E. coli BL21 (DE3) and 
transformants. Strains were grown at 37 °C overnight in 1 mL LB. 500μL of overnight 
culture was transferred to 50 mL fresh LB and grown at 37 °C to an OD600 of 0.6. Protein 
expression was induced by the addition of 0.5 mM IPTG, the temperature was lowered to 
16 °C and the cells were grown for a further 18 hours. Cells were collected by 
centrifugation at 5000g for 10 minutes, and washed twice with 50 mM Tris-HCl buffer (pH 
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7.5) or PBS (pH 7.4). Cells (0.2 g wet weight) were resuspended in 20 mL 50 mM Tris-HCl 
buffer (pH 7.5) or PBS and 0.25M NaCl (pH 7.4) with 10 mM 2-keto-L-gulonate. The 
biotransformation reaction was performed at 30 °C for 24 h and monitored by taking 1 
mL aliquots for HPLC analysis. 
HPLC Analysis 
Samples (1 mL) were centrifuged at 14,800 rpm for 10 min and the supernatant filtered 
through a 0.45 μm filter and used for analysis. The concentration of 2-keto-L-gulonate was 
determined by HPLC using a ROA-Organic Acid Column (300 x 7.8 mm, Phenomenex) with 
5.0 mM H2SO4 as eluent and a flow rate of 0.5 mL min-1. The column was maintained at 55 
°C. Peaks were detected at 210 nm. 
Production and Analysis of Sesquiterpenoid Compounds 
Plasmid Construction 
Yeast plasmids used were derived from pESC-LEU2d. All plasmids used for production of 
sesquiterpenoid compounds are outlined in Table 2-5. All sesquiterpene synthases were 
cloned from Vitis vinifera cv. Shiraz. For α-guaiene production, TPS24 was codon 




Table 2-5 Plasmids used for production and analysis of sesquiterpenoid compounds 
Plasmid Description Source 
pESC-LEU2d Expression vector containing GAL1-GAL10 
divergent promotor, 2μ origin, LEU2 
marker 
Agilent 
pESC-LEU2d-TPS24 TPS24 gene inserted into HindIII/NheI 
sites of pESC-LEU2d 
This study 
pESC-LEU2d-BM3WT Wild-type P450BM3 gene inserted into 
XhoI/BamHI sites of pESC-LEU2d 
This study 
pESC-LEU2d-BM3Mut Mutant P450BM3 gene inserted into 































































Yeast Strains and Cultivation 
Sesquiterpenoids were microbially synthesised by the yeast strain EPY300 (S288C, MATα 
his3Δ1 leu2Δ0 PGAL1–tHMG1::δ1 PGAL1–upc2-1::δ2 erg9::PMET3–ERG9::HIS3 PGAL1–
ERG20::δ3 PGAL1–tHMG1::δ4). EPY300 has been metabolically engineered to overproduce 
the sesquiterpene precursor farnesyl pyrophosphate (FPP) (Nguyen, MacNevin & Ro 
2012).  EPY300 was freshly streaked out from glycerol stocks and revived on YPD media. 
It was selected for on SC-His-Met media. pESC-Leu transformants were selected for on SC-
His-Met-Leu media. Yeast strains were grown in appropriate SC media with 2% glucose as 
the carbon source. To induce sesquiterpene synthesis, transformants were grown in SC 
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media with 1.8% galactose, 2% glucose and 1 mM methionine. All yeast liquid cultures 
were grown at 28° C, 140 rpm and all plates grown at 30° C.  
Yeast Transformation 
The transformation protocol used was based on the LiAc/SS carrier DNA/PEG method 
(Gietz & Schiestl 2007). EPY300 was cultured overnight in 1 mL SC-His-Met 2% glucose at 
28 °C. 500 μL of pre-inoculum was transferred to fresh SC-His-Met (25 mL) and grown at 
28 °C for 4 hours. Cells were harvested by centrifugation and washed in 0.1 M Lithium 
Acetate (25 mL), then centrifuged again and resuspended in 0.4 mL 0.1 M Lithium Acetate.  
100 ng of DNA were added to a transformation mixture consisting of the following: 50 μL 
EPY300 cells, 240 µL 50 % Polyethylene Glycol, 36 µL 1 M Lithium Acetate, 50 µL salmon 
sperm DNA (prepared by boiling 10 minutes then immediately chilling on ice for 5 
minutes) and 29 µL sterile water. The transformation mixture was incubated at 30 °C for 
30 minutes then 42 °C for 30 minutes. The cells were collected by centrifugation, washed 
with sterile saline (0.5 mL) and resuspended in 50 µL sterile water. The cell suspension 
was plated on appropriate selective agar and incubated at 30 °C for 3 days.  
Metabolite Analysis 
EPY300 – pESC LEU transformants were used for the production of sesquiterpenoids in 
vivo. A single colony was picked and inoculated in 5 mL appropriate SC media and grown 
overnight (15 – 18 hours) at 28 °C with shaking (140 rpm). 1 mL of pre-inoculum was 
transferred to 30 mL fresh SC media with 1.8% galactose, 0.2% glucose and 1 mM 
methionine. Cultures were incubated at 28 °C with shaking (140 rpm) for 3 days. The 
medium (30 mL) was extracted with ethyl acetate (5 mL) by vortexing for 20 seconds, 
followed by centrifugation to separate the organic and aqueous phases. The organic 
fraction was collected for GC-MS analysis. Samples (1 mL) were concentrated to 250 μL 
using a gentle flow of N2 gas.  
For analysis of products of P450BM3, cultures of EPY300 expressing P450BM3 were cultured 
as above and the culture medium spiked with 0.5 μg/mL α-caryophyllene or β-
caryophyllene. The medium (30 mL) was extracted with ethyl acetate (5 mL) as described 
above but samples were not concentrated before GC-MS analysis. 
Sesquiterpene production was analysed by GC-MS using helium as carrier gas at a flow 
rate 1 mL/ min. The injector was in a splitless mode with an inlet temperature set at 
300 °C. The GC oven temperature was initially 50 °C and held for 1 minute then ramped at 
8  °C/min to 300 °C and held for 17.75 min. Mass fragments were detected by normal 
scanning over a range of m/z 33 to 500. Detection was carried out in positive ion mode. 
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Compounds produced were identified by comparison of retention times and mass spectra 
to those of authentic standards or by reference spectra in the National Institute of 
Standards and Technology library. 
α-Guaiene production was analysed using GC-MS using helium as carrier gas at a flow rate 
1 mL/ min. The injector was in splitless mode with an inlet temperature set at 250 °C. The 
GC oven temperature was initially 100 °C, then ramped at 20 °C/min to 250 °C, then 
ramped at 30 °C/min to 300 °C and held for 3 minutes.  
Homology Modelling  
Protein-protein Basic Local Alignment Search Tools (BLAST) were used to identify a 
protein in the Protein Data Bank (PDB) database with homology to V. vinifera P450s. The 
coordinates for Human Cytochrome P450 CYP17A1 were downloaded from the PDB 
(accession number 3RUK). Protein structure was modelled by satisfaction of spatial 
restraints using MODELLER 9.19 (Sali & Blundell 1993). Models were evaluated using 
VADAR (Volume, Area, Dihedral Angle Reporter) (Willard et al. 2003). Docking was 
performed using AutoDock 4.2.6 (Morris et al. 2009). The charge on the porphyrin iron 
was manually set to +0.400 e, corresponding to Iron(II), and the charges on the ligating 
nitrogens set to -0.348 e to compensate. The grid box (60 x 60 x 60 points with a grid 
spacing of 0.375 Å) was centred around the haem iron. A total of 150 docking runs were 
performed using a Lamarckian Genetic Algorithm with default parameters. Resulting 
conformations were ranked by binding energy and evaluated by determining distance 
between hydroxylation sites and the haem iron. All figures were generated using PyMOL 
(DeLano Scientific LLC, San Francisco, CA, USA). Multiple sequence alignment was 




Chapter 3 Identification and Characterisation of 
Potential Grapevine 2-Ketogulonate Reductases 
Introduction 
Tartaric acid (TA) is found in many species of plants, but only accumulates in a few 
species, including grapevine (Vitis vinifera) (Stafford 1959). During grape berry 
development, TA levels increase rapidly during the first four weeks after flowering and 
then remain stable after ripening, reaching levels of up to 10 mg per berry (Iland & 
Coombe 1988; Saito & Kasai 1968). TA is essential to the winemaking process as it raises 
the acidity of the wine must which prevents microbial spoilage and discolouration 
(Kalathenos, Sutherland & Roberts 1995). Importantly, is not broken down during 
fermentation and maturation, so exogenous TA is often added during the winemaking 
process. TA also contributes to the palatability, flavour and mouthfeel of wine (Plane, 
Mattick & Weirs 1980). No physiological role however has yet been attributed to its 
formation and accumulation in grapevine. 
Despite the importance of TA to the winemaking industry, relatively little is known about 
its biosynthesis. Early experiments have shown that most TA is synthesised from ascorbic 
acid via a C4/C5 cleavage pathway (Saito & Loewus 1989). Radiolabelling experiments 
revealed that ascorbic acid fed to grapevine is converted to 2-keto-L-gulonate, then L-
idonate, then to 5-keto-D-gluconate, which is cleaved to form tartaric acid semialdehyde, 
the direct precursor to tartaric acid (Saito 1992; Saito & Kasai 1984). Kinetic studies 
suggest the rate-limiting step of the reaction is the conversion of L-idonate to 5-keto-D-
gluconate (Malipiero, Ruffner & Rast 1987).  
Although the pathway intermediates have been well-established, few of the enzymes 
involved in the pathway have been identified. L-idonate dehydrogenase (IdnDH), which 
catalyses the conversion of L-idonate to 5-keto-D-gluconate, was the first enzyme in this 
pathway to be characterised (DeBolt, Cook & Ford 2006). This enzyme was found to be 
highly specific, with no activity detected against alternative substrates tested. 
Additionally, a grapevine 2-keto-L-gulonate reductase (2KGR) identified via 
bioinformatics has been partially characterised in vitro (Burbidge 2011; Jia 2015). This 
enzyme is capable of interconverting 2-keto-L-gulonate and L-idonate, but also acts as a 
reductase on a number of other substrates, including ascorbate, D-gluconate and L-idonate 
(Burbidge 2011). Further evidence, including in planta experiments, is required to 
confirm its involvement in the TA biosynthetic pathway. A limiting factor in the study of 
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tartaric acid biosynthesis is the limited commercial availability of L-idonate. Cheap and 
efficient production of L-idonate would greatly benefit further research in this field.  
 This study focuses on the identification and characterisation of new 2KGR candidates, 
and the development of a system for microbial production of L-idonate.  
Comparison between grapevine enzymes and enzymes from other species with known 
activity can serve as a foundation for identification of enzymes involved in the TA 
biosynthesis pathway. The conversion of 2-keto-L-gulonate to L-idonate is a fairly unusual 
reaction within nature, and only a handful of enzymes have been identified with this 
activity. The previously characterised Vv2KGR was identified based on similarity to an 
Escherichia coli enzyme that is able to reduce 2-keto-L-gulonate to L-idonate, but with low 
activity and specificity (Burbidge 2011; Yum et al. 1998). More recently, two fungal 2KGRs 
capable of interconverting 2-keto-L-gulonate and L-idonate were identified in Aspergillus 
niger (Kuivanen, Arvas & Richard 2017; Kuivanen et al. 2016). These enzymes, GluC and 
GluD, are the first substrate-specific 2KGRs to be reported and may offer new avenues for 
the identification of previously unrecognised 2KGRs within the grapevine genome.  
If a suitable new 2KGR is found, it may be used for the microbial production of L-idonate. 
Otherwise, the previously identified Vv2KGR, or a 2KGR from another species, may be 
used. Microbial biosynthesis is a versatile method of obtaining useful products, and offers 
several advantages over chemical synthesis (Du, Shao & Zhao 2011). Most importantly for 
this purpose, microbial biosynthesis has the ability to be regio- and stereoselective, which 
will increase product yield and facilitate straightforward purification. 2-keto-L-gulonate is 
an intermediate in ascorbic acid synthesis, making it a relatively cheap compound that can 
be used as a feedstock for the bioconversion of 2-keto-L-gulonate to L-idonate (Grindley et 
al. 1988). This reaction can be performed in vitro using purified soluble or immobilised 
enzymes, or via whole-cell biotransformation, using metabolically dormant cells 
containing the desired enzyme activity (Faber 2004). Whole-cell biotransformation is 
preferred over the use of a cell-free extract as it eliminates the need for protein 
purification and improves enzyme stability. Furthermore, whole-cell systems circumvent 
the need to supply exogenous cofactor and can be engineered to provide facile cofactor 
regeneration (Duetz, Van Beilen & Witholt 2001).  
In this study, four potential grapevine 2KGRs were identified based on homology to the 
A. niger 2KGRs GluC and GluD. Two of these enzymes were expressed in E. coli and 
purified, and the kinetic parameters of the recombinant proteins were investigated in 
vitro. Additionally, the feasibility of constructing a whole-cell biotransformation system 




To search for potential grapevine 2-keto-L-gulonate reductases (2KGRs), a protein-
protein BLAST search (BLASTP) was performed against the V. vinifera genome on the 
NCBI database using the fungal 2KGRs GluC and GluD to identify homologues. GluC gave 
24 hits (17 with score >80) (Table 3-1), and GluD gave 29 hits (23 with score >80) (Table 
3-2). All of the hits from GluC were also included in the GluD results for a total of 29 
unique hits. Several of these candidates had been previously identified by Burbidge 
(2011) but only one (XP_003632860.1) was expressed and purified. XP_003632860.1 was 
found to have 2KGR activity in vitro and will be referred to in this study as Vitis vinifera 




Table 3-1 BLASTP hits of Aspergillus niger strain ATCC protein GluC against Vitis vinifera proteome. The accession number is from the NCBI database. The max score describes the highest 
alignment score between the query sequence and the database sequence segment, the query cover describes the percent of the query length included in the aligned segments and the 








XP_002281980.1 PREDICTED: glyoxylate/hydroxypyruvate reductase HPR3 105 74% 29% 
XP_002284520.1 PREDICTED: hydroxyphenylpyruvate reductase 102 78% 29% 
XP_002282078.1 PREDICTED: glyoxylate/hydroxypyruvate reductase HPR3 99 74% 30% 
XP_002285358.1 PREDICTED: D-3-phosphoglycerate dehydrogenase 1, chloroplastic 96.7 74% 29% 
XP_002283022.1 PREDICTED: D-3-phosphoglycerate dehydrogenase 3, chloroplastic 96.7 74% 29% 
CBI19470.3 unnamed protein product 96.7 74% 29% 
XP_003632860.1 PREDICTED: hydroxyphenylpyruvate reductase 92.4 85% 30% 
CAN64820.1 hypothetical protein VITISV_009548  89.4 50% 31% 
CBI38817.3 unnamed protein product 91.3 75% 25% 
XP_003633919.1 
PREDICTED: glyoxylate/hydroxypyruvate reductase HPR3 isoform 
X1 89.4 73% 25% 
XP_010661599.1 
PREDICTED: glyoxylate/hydroxypyruvate reductase HPR3 isoform 
X2  87.4 73% 25% 
CBI36125.3 unnamed protein product 86.3 73% 31% 
XP_002273552.1 PREDICTED: D-3-phosphoglycerate dehydrogenase 3, chloroplastic 86.3 74% 27% 
CAN65023.1 hypothetical protein VITISV_020147  81.3 73% 25% 
XP_002279281.1 PREDICTED: glycerate dehydrogenase HPR, peroxisomal isoform X1 81.3 73% 25% 
CBI40269.3 unnamed protein product  80.9 50% 32% 
XP_019074661.1 PREDICTED: glycerate dehydrogenase isoform X2 80.1 72% 25% 
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Table 3-2 BLASTP hits of Aspergillus niger strain ATCC protein GluD against Vitis vinifera proteome. The accession number is from the NCBI database. Highlighted sequences were 






XP_002284520.1 PREDICTED: hydroxyphenylpyruvate reductase  154 81% 37% 
XP_002281980.1 PREDICTED: glyoxylate/hydroxypyruvate reductase HPR3  141 74% 36% 
XP_002282078.1 PREDICTED: glyoxylate/hydroxypyruvate reductase HPR3 141 74% 38% 
XP_010661599.1 
PREDICTED: glyoxylate/hydroxypyruvate reductase HPR3 isoform 
X2  139 79% 35% 
XP_003632860.1 PREDICTED: hydroxyphenylpyruvate reductase 135 81% 35% 
XP_003633919.1 
PREDICTED: glyoxylate/hydroxypyruvate reductase HPR3 isoform 
X1 136 74% 35% 
CBI19470.3 unnamed protein product 138 67% 36% 
XP_002283022.1 PREDICTED: D-3-phosphoglycerate dehydrogenase 3, chloroplastic  139 67% 36% 
XP_002273552.1 PREDICTED: D-3-phosphoglycerate dehydrogenase 3, chloroplastic 139 67% 37% 
XP_002285358.1 PREDICTED: D-3-phosphoglycerate dehydrogenase 1, chloroplastic 137 67% 36% 
CBI36125.3 unnamed protein product  129 70% 36% 
CBI38817.3 unnamed protein product 135 78% 33% 
CAN68604.1 hypothetical protein VITISV_036580 124 61% 37% 
CAN64820.1 hypothetical protein VITISV_009548 116 55% 38% 
CBI25279.3 unnamed protein product   115 49% 39% 
CAN77384.1 hypothetical protein VITISV_006350   111 51% 38% 
CAN65023.1 hypothetical protein VITISV_020147   110 67% 31% 
XP_019074661.1 PREDICTED: glycerate dehydrogenase isoform X2   110 67% 31% 
XP_002279281.1 PREDICTED: glycerate dehydrogenase HPR, peroxisomal isoform X1   109 67% 31% 
CBI40269.3 unnamed protein product   109 49% 37% 
XP_002278444.1 PREDICTED: formate dehydrogenase, mitochondrial   94 67% 30% 
CAN71454.1 hypothetical protein VITISV_036417   94 67% 30% 
CBI34779.3 unnamed protein product   79.7 74% 30% 
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The families, sites and domains of the top 10 BLAST results were analysed for similarities 
to GluC and GluD using InterPro (Table 3-3). Predicted chloroplastic proteins were not 
analysed as TA synthesis is most likely to occur in the cytoplasm (Wen et al. 2010). The 
top five BLAST results showed the most similarity to the GluC and GluD domains. All 
proteins analysed shared the same NAD(P)H binding domain signature and a D-isomer 
specific 2-hydroxyacid dehydrogenase catalytic domain. Lower-ranked BLAST results had 
additional domains that were not present in the GluC and GluD proteins, including an S-
adenosyl-L-homocysteine hydrolase domain, an NAD binding domain and an ACT domain. 
These proteins were classified as members of the D-3-phosphoglycerate dehydrogenase 
family and were discounted from further analysis. No protein families were identified for 
the earlier results. The top four results were selected for additional investigation due to 
their strong homology and similarity of binding domains with GluC and GluD. The fifth 
candidate, Vv2KGR0 also shared a majority of domains with GluC and GluD but has 
already been studied in vitro. The DNA sequences and amino acid sequences of the 





Table 3-3 Summary of domains present in A. niger 2KGRs and V. vinifera homologues. Domains were identified 
using InterPro (http://www.ebi.ac.uk/interpro/). No families were identified except for those with additional s-
adenosyl-L-homocysteine hydrolase, NAD binding and ACT domains. These proteins were classed as members of 
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Hacid_dh_C x x x x x x x x x x x x 
D 2 Hydroxyacid 
Dh 1 x x x    x  x x  x 
D 2 Hydroxyacid 
Dh 2          x x  x 
D 2 Hydroxyacid 
Dh 3 x x             x x   x 
Additional domains*                   x x x 




























































































To determine if the candidate 2KGR expression patterns are likely to be temporally and 
spatially consistent with TA synthesis, gene expression was analysed using Expression 
Atlas (Petryszak et al. 2016). Limited data was available from a small number of studies 
using different varieties of grapes. One study by Palumbo et al. (2014) measured the gene 
expression in berries at different stages of development. These data are most relevant 
since TA synthesis occurs in the berry during development. The expression data is 
presented in Table 3-4. The relative expression of the four 2KGR candidates was 
compared to previously identified L-idonate dehydrogenase (LIDH) and Vv2KGR0 
proteins.  
Table 3-4 Relative expression of V. vinifera proteins at various stages of berry development. Expression was 
analysed using Expression Atlas (https://www.ebi.ac.uk/gxa/home/).  LIDH: L-idonate dehydrogenase; Vv2KGR0: 
V. vinifera 2-keto-L-gulonate reductase 
  Expression in Berry 
  Pea-sized Beginning to touch Soft Ripe for harvest 
XP_002284520.1 Low Not detected Low Low 
XP_002281980.1 Med Low Low Low 
XP_002282078.1 Not detected Med Med Med 
XP_010661599.1 Low Low Low Low 
LIDH Med Med Med Med 
Vv2KGR0 Med Med Med Med 
  
To further characterise the potential candidates, TargetP (Emanuelsson et al. 2007) was 
used to predict their subcellular localisation (Table 3-5). XP_002282078.1 was predicted 
to localise to the mitochondria. The other three candidates analysed did not contain a 
signal peptide for mitochondria, chloroplasts or secretory pathways. None of the 
candidates were predicted to contain transmembrane helices.  
Finally, Spider2 (http://sparks-lab.org/server/SPIDER2/) was used to predict regions of 
secondary structure. This was to check for long unstructured regions at the beginning or 
end of the protein sequence, which could pose problems for expressing, purifying or 
crystallising the protein in future investigations. XP_002282078.1 was predicted to have 
an unstructured region of approximately 30 amino acids at the N terminus. All other 




Table 3-5 Chromosome location, subcellular localisation prediction and length of 2KGR candidates. Subcellular 
localisation and transmembrane helices were predicted using CBS Prediction Services 
(http://www.cbs.dtu.dk/services/).  
 
Chromosome Subcellular Localisation 
Transmembrane 
Helices Length (aa) 
XP_002284520.1 9 other* 0 313 
XP_002281980.1 2 other* 0 314 
XP_002282078.1 2 mitochondria 0 334 
XP_010661599.1 15 other* 0 321 
 *other denotes location other than chloroplast, mitochondria or secretory pathway 
Based on these results, candidates XP_002284520.1 (UniProt D7U0H8) and 
XP_002281980.1 (UniProt F6HUJ6) were chosen for expression and purification. 
Henceforth, they will be referred to as 2KGR1 and 2KGR2 respectively.  
The two 2KGR candidates were cloned into pET-11a and expressed in E. coli BL21. 2KGR1 
was predicted to be 34.0 kDa and 2KGR2 was predicted to be 33.9 kDa. High levels of both 
proteins were produced; however, they showed poor solubility in Buffer A (Figure 3-2). 
Expression tests were performed at 37 °C, 30 °C and 16 °C and it was found that 
expression of 2KGR1 was highest at 37 °C after 4 hours and expression of 2KGR2 was 
highest at 30 °C after 6 hours. However, expression under optimised conditions failed to 
produce a large amount of soluble protein. Solubility tests were performed using a range 
of buffers, but neither 2KGR1 nor 2KGR2 were sufficiently soluble for purification 




Figure 3-2 Expression of 2-keto-L-gulonate reductase candidates in E. coli visualised by SDS PAGE. 1. Protein 
Standard Lanes 2-3 are from 2KGR1expression: 2. Insoluble fraction 3. Soluble fraction; Lanes 4-5 are from 
2KGR2expression: 4. Insoluble fraction 5. Soluble fraction; 2KGR1 and 2KGR2 are circled in yellow and red 
respectively. 
To determine if the 2KGR1 and 2KGR2 proteins were catalytically active in vivo, whole-
cell biotransformation of 2-keto-L-gulonate was attempted using E. coli BL21 strains 
expressing each of the 2KGR candidates (Figure 3-3). No difference in 2-keto-L-gulonate 





























Figure 3-3 Whole-cell biotransformation of 2-keto-L-gulonate was attempted using E. coli expressing the 2KGR 
candidates. Assays were performed using 0.3g cell wet weight with 10 mM 2-keto-L-gulonate substrate in 50 mM 
tris-HCl buffer (pH 7.5) at 30 °C. There was  no evidence of enzyme activity compared to the no plasmid control.  
In order to obtain soluble protein for purification, 2KGR1 and 2KGR2 were each fused 
with NusA. The size of the 2KGR1-NusA and the 2KGR2-NusA fusion proteins were each 
predicted to be 94 kDa. The fusion proteins were expressed in E. coli BL21 and showed 
high levels of expression and good solubility in Buffer A (Figure 3-4). 2KGR1-NusA and 
2KGR2-NusA were expressed and purified for further analysis. 
 
Figure 3-4 Expression of 2KGR-NusA fusion proteins visualised by SDS-PAGE. Lanes 1 and 15 are protein 
standard. Lanes 2-8 are from 2KGR1-NusA expression: 2. Soluble fraction from IPTG-induced cells (+IPTG) 3. 
Soluble fraction from non-induced cells (-IPTG) 4,5. Insoluble fraction +IPTG, 6,7. Insoluble fraction –IPTG.. Lanes 
9-14 are from 2KGR2-NusA expression:  9. Soluble fraction +IPTG 10. Soluble fraction -IPTG 11,12.. Insoluble 
fraction +IPTG, 13,14 Insoluble fraction –IPTG. 2KGR1 and 2KGR2 in the soluble fraction are circled in yellow and 
red respectively.  
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Purified 2KGR1-NusA and 2KGR2-NusA were used in enzyme assays to explore the 
potential of 2-keto-L-gulonate reductase activity. The pH conditions under which each 
enzyme was most active were investigated using two different buffers to ensure 
differences in activity were due to pH and not buffer composition. Both enzymes were 
found to be most active at pH 7.0 and favoured Tris buffer over HEPES (Figure 3-5). Tris 
7.0 buffer was used for all future experiments. 
 
Figure 3-5 Activity of recombinant 2KGR1 and 2KGR2 at various pH in 100 mM Tris and HEPES buffers. Assays 
were performed with 0.5 μg purified enzyme, 40 mM 2-keto-L-gulonate and 0.25 mM NADH at 37° C. Plotted 
values represent the mean of duplicate assays with error bars representing the Standard Error of the Mean.  
2KGR1 and 2KGR2 are hypothesised to be involved in the conversion of 2-keto-L-gulonate 
to L-idonate in the tartaric acid biosynthesis pathway. Therefore their activity was 
analysed using 2-keto-L-gulonate as substrate. 2KGR1 and 2KGR2 activity was tested 
against varying concentrations of 2-keto-L-gulonate (Figure 3-6, Figure 3-7). A hyperbolic 
curve was fitted to the data, however, neither enzyme reached saturation, so the kinetic 
model is undetermined. Assuming Michaelis–Menten kinetics, 2KGR2 has a Vmax of 0.44 ± 
0.4 μmoles/min/mg protein and a KM of 6.38 ±0.97 mM. The Vmax and KM of 2KGR1 could 




Figure 3-6 Activity of 2KGR1 against varying concentrations of 2-keto-L-gulonate. Assays were performed with 
0.5 μg purified enzyme and 0.25 mM NADH in 100 mM Tris 7.0 at 37° C. Plotted values represent the mean of 
triplicate assays with error bars representing the Standard Error of the Mean.  
 
Figure 3-7 Activity of 2KGR2 against varying concentrations of 2-keto-L-gulonate. Assays were performed with 
0.5 μg purified enzyme and 0.25 mM NADH in 100 mM Tris 7.0 at 37° C. Plotted values represent the mean of 
triplicate assays with error bars representing the Standard Error of the Mean. The trendline represents the 
hyperbolic curve of Michaelis-Menten kinetic analysis fitted using GraphPad prism 8.0. Inset: double-reciprocal 
Lineweaver-Burk plot. 
To determine the products of 2KGR1 and 2KGR2 using 2-keto-L-gulonate as a substrate, 
an in vitro enzyme reaction was performed using 5 μg purified enzyme, 100 mM Tris 7.0, 
40 mM 2-keto-L-gulonate (substrate) and 0.25 mM NADH in 1 mL total volume. The 
reaction mixture was analysed by HPLC (Figure 3-8). No new product peak was present 
and there was no evidence for the formation of L-idonate. L-idonate would be expected to 























elute at 11.8 min (Supplementary Figure 3-2). The concentration of 2-keto-L-gulonate did 
not significantly decrease after 2 hours reaction time compared to the no enzyme control.  
 
Figure 3-8 HPLC Chromatogram of in vitro enzyme reaction. The reaction mixture consisted of 0.5 μg purified 
enzyme, 100 mM Tris 7.0, 40 mM 2-keto-L-gulonate (substrate) and 0.25 mM NADH. The reaction mixture was 
incubated at 37°C for 2 hours. No new product is present in the recombinant enzyme samples compared to the no 
enzyme control.  
The activity of 2KGR1 and 2KGR2 was tested against a range of substrates, which were 
selected due to their presence in V. vinifera metabolic pathways (Figure 3-9). 2KGR1 
displayed activity against 2-keto-L-gulonate, ascorbate and glyoxylate, and no activity 
against 5-keto-D-gluconate. Likewise, 2KGR2 displayed a similar, but slightly lower, level 






























































Figure 3-9 Substrate activity of purified 2KGR1 and 2KGR2. Assays were performed with 0.5 μg purified enzyme, 
40 mM substrate and 0.25 mM NADH in 100 mM Tris 7.0 at 37° C. The bars represent the mean of triplicate 
assays with error bars representing the Standard Error of the Mean.  
Since there was no evidence that either 2KGR1 or 2KGR2 produced L-idonate from 2-keto-
L-gulonate, these enzymes were determined unsuitable for the whole-cell production of L-
idonate. Instead, the previously identified Vv2KGR0 (Burbidge 2011; Jia 2015) was used. 
The whole-cell reaction was performed using E. coli BL21 expressing Vv2KGR0 with 0.090 
g cell wet weight in 1 x PBS (pH 7.4) containing 0.25 M NaCl and 10 mM 2-keto-L-gulonate 
at 30 °C. The products were analysed by HPLC (Figure 3-10). After 24 hours, no 
production of L-idonate was observed, nor was there a significant decrease in 2-keto-L-




Figure 3-10 Overlay of HPLC chromatograms of whole-cell biotransformation using the previously identified 
Vv2KGR0. The reaction was performed using 0.090 g cell wet weight in 1 x PBS (pH 7.4) containing 0.25 M NaCl 
and 10 mM 2-keto-L-gulonate at 30 °C. Other peaks in the chromatogram are due to the PBS solution. 
 
Discussion 
Tartaric acid (TA) accumulates in grape berries during ripening and is essential to the 
winemaking process. It lowers the pH of the wine must, preventing discolouration and 
microbial spoilage, and confers a ‘sharp’ acidic taste to the wine (Kalathenos, Sutherland 
& Roberts 1995). Despite the importance of tartaric acid, its biosynthetic pathway has not 
been fully elucidated. Two enzymes have been identified in the pathway: L-idonate 
dehydrogenase, which catalyses the interconversion of L-idonate and 5-keto-D-gluconate 
(DeBolt, Cook & Ford 2006), and a 2-ketogulonate reductase (2KGR) (Burbidge 2011). 
Research in this area has been hindered by a lack of commercially available L-idonate. The 
aim of this study was to identify potential novel isoforms of 2KGR and construct a 
microbial system to biosynthesise L-idonate. 
To identify potential V. vinifera 2KGRs, a BLASTp search was performed against two 
fungal 2KGRs, GluC and GluD to compare amino acid sequences. Although some 
candidates had previously been identified by Burbidge (2011), including Vv2KGR0 which 
was confirmed to have 2-keto-L-gulonate reductase activity in vitro, a number of new 
candidates were found. The top hits had between 35-39% identity over the open reading 
frame (ORF). In general, evidence suggests that sequences that share more than 40% 
identity are highly likely to share functional similarity, but it is difficult to reliably infer 
functional similarity at greater evolutionary distances (Pearson 2013). The 35-39% 
shared sequence identity over the evolutionary distance between fungi and grapevine 
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indicates these enzymes are possibly distantly related and are likely to share function. 
Amino acid alignments of GluD with the four 2KGR candidates selected for further 
investigation show short homologous regions of up to 10 amino acids in length, possibly 
denoting key catalytic motifs (Figure 3-11).  
 
Figure 3-11 Sequence alignment of GluD and the top four 2KGR candidates selected for further investigation. 
Many genes have low or no expression in vivo, so gene expression databases were 
analysed to examine the expression patterns and levels of the candidate genes. Tartaric 
acid (TA) accumulates in berry and leaf tissue and accumulates rapidly during early 
development, plateauing after ripening (Ruffner 1982; Saito & Kasai 1968). Thus, 
enzymes involved in TA synthesis would be expected to be expressed throughout 
development in the berries. Expression data for the candidate enzymes is limited, and 
there is little consistency across experiments in terms of tissues and time points sampled, 
making it hard to combine data from multiple studies. Most studies available on 
Expression Atlas analysed expression in different varieties or tissues rather than berry 
stages. The expression data presented in Table 3-4 is based on a single study by Palumbo 
et al. (2014) that looked at expression differences across different stages of berry 
development. The expression is ranked on a scale of Low-Med-High, so this data is limited 
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and can be used for comparative purposes only. None of the candidates displayed an 
expression level as high as the previously identified LIDH and Vv2KGR0 enzymes, which 
surprisingly were still expressed in berries ripe for harvest, a time when TA synthesis is 
minimal.  
Current evidence suggests tartaric acid synthesis occurs in the cytoplasm. Firstly, ascorbic 
acid, the precursor to TA, is found in relatively high concentrations in the cytoplasm 
(Davey et al. 2000). Secondly, L-idonate dehydrogenase (IdnDH), the rate limiting enzyme 
of the primary TA biosynthetic pathway in grapes, is mainly located in the cytoplasm 
(Wen et al. 2010). Finally, since TA intermediates are found only in low concentrations 
inside the cell, the enzymes for TA synthesis are likely to co-localise to increase the local 
concentration gradient of substrate (Weeks & Chang 2011). Several candidates were 
predicted to localise to the chloroplast by the NCBI database. These proteins were 
discounted from future analysis as they are spatially unlikely to be involved in TA 
synthesis. Further characterisation of candidates was performed using TargetP to predict 
subcellular localisation. Candidate XP_002282078.1 was predicted to localise to the 
mitochondria and thus also unlikely to be involved in TA synthesis. TargetP accurately 
predicts the localisation of 80-90% of chloroplastic and mitochondrial proteins in 
Arabidopsis thaliana, so this prediction is likely to be valid (Leister 2003). None of the 
candidates were predicted to contain transmembrane helices, so they are unlikely to be 
membrane-bound.  
These analyses suggest, based on homology to previously identified 2KGRs, expression 
patterns, and predicted subcellular localisation, that XP_002284520.1 and 
XP_002281980.1 are good candidates for 2-keto-l-gulonate reductase activity in V. 
vinifera. These candidates were selected for in vitro characterisation and further study 
(2KGR1 and 2KGR2).  
Expression of 2KGR1 and 2KGR2 in E. coli BL21 did not produce sufficient quantities of 
soluble protein for purification (Figure 3-2). Even after expression conditions were 
optimised, neither 2KGR1 nor 2KGR2 was found to be soluble in a range of different 
buffers. Whole-cell biotransformation of 2-keto-L-gulonate was attempted using E. coli 
BL21 strains expressing each of the 2KGR candidates, but no difference was observed 
between the control strain and the 2KGR-expressing strains. (Figure 3-3). Therefore, it is 
likely that the proteins were catalytically inactive and sequestered in inclusion body 
aggregates.  
It is possible to recover aggregated proteins from inclusion bodies by solubilisation with a 
denaturant followed by removal of the denaturant under conditions optimal for protein 
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folding (Lilie, Schwarz & Rudolph 1998). However, the specific folding conditions must be 
optimised for each protein, and the final yield of correctly folded protein may still be low 
(Harrison 2000). An alternative approach is to use a fusion tag to enhance the solubility of 
the expressed protein. An affinity-tagged (6 His) E. coli N-utilization substance A (NusA) 
protein was chosen for this purpose as it is predicted to be over 95% soluble and has been 
evaluated against a range of proteins (Davis et al. 1999). Expression of the 2KGR1-NusA 
and 2KGR2-NusA fusion proteins in E. coli BL21 was successful and produced high yields 
of soluble protein for purification (Figure 3-4).  
The NusA fusion tag was not removed from the purified protein before enzymatic 
analysis. It is possible in some cases to use a protease to cleave the linker between the 
solubility tag and the protein of interest, but this can cause problems including 
incomplete cleavage or re-aggregation of the target protein (Esposito & Chatterjee 2006). 
As NusA is a large protein, its presence may however affect the activity of the 2KGRs.  
Purified 2KGR1-NusA and 2KGR2-NusA were used to investigate the activity of the 
candidate 2KGRs against 2-keto-L-gulonate. Cofactory (Geertz-Hansen et al. 2014) was 
used to predict the cofactor preference of the two 2KGRs. Both were predicted to contain 
domains specific to NADH only. Therefore, NADH was used for analysis of enzyme activity. 
The reaction was monitored by measuring the change in absorbance due to oxidation of 
NADH. A decrease in absorbance was observed only after the addition of substrate, 
indicating that oxidation was due to 2KGR activity. The optimal pH conditions for each 
enzyme were investigated using two different buffers to ensure differences in activity 
were due to pH and not buffer composition. Both enzymes were found to be most active at 
pH 7.0 in Tris buffer (Figure 3-5). Other reaction conditions, including temperature and 
substrate and cofactor concentrations, were based on previous optimisation for kinetic 
studies on the similar Vv2KGR0 protein (Burbidge 2011). 
The activities of 2KGR1 and 2KGR2 against increasing concentrations of 2-keto-L-gulonate 
were analysed (Figure 3-6, Figure 3-7). However, at lower substrate concentrations, the 
change in absorbance was too low to precisely measure, and it appears the enzymes did 
not reach substrate saturation. It may be necessary to use a higher concentration of 
enzyme and greater concentration of substrate in order to accurately model the kinetics 
of these enzymes. Graphpad Prism 8.0 was used to fit a Michaelis-Menten kinetic model to 
the data. The model had an R2 value of 0.91 for the 2KGR1 data and 0.96 for the 2KGR2 
data. While this model is a relatively good fit, the Vmax and Km values for 2KGR1 could not 
be determined within a narrow confidence interval due to lack of data at higher 2-keto-L-
gulonate concentrations. A double reciprocal Lineweaver-Burk plot was used to 
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determine a Vmax of 0.44 μmoles/min/mg protein and a Km of 6.38 mM for 2KGR2. While 
these 2KGR enzymes appear to display Michaelis-Menten kinetics, there is evidence that 
the previously identified Vv2KGR0 operates under an allosteric model, although with 
minimal cooperation effects (Burbidge 2011). Time-course studies have shown that the 
dehydration of L-idonate is the rate-limiting step of tartaric acid synthesis (Malipiero, 
Ruffner & Rast 1987), although there may be multiple points of control along the 
biosynthetic pathway. In order to accurately determine the kinetics of the 2KGR1 and 
2KGR2 candidates, the analysis should be repeated with higher 2-keto-L-gulonate 
concentrations to ensure both enzymes reach saturation. However, 40mM of substrate 
was sufficient to saturate the previously investigated Vv2KGR, suggesting that if higher 
substrate concentrations are needed to investigate the candidate 2KGR activities, the 
reduction of 2-keto-L-gulonate may not be their primary reaction.  
The Km of 2KGR2 was calculated as 6.38 mM ± 0.97. This is of the same magnitude as the 
calculated Km of 4.67 mM for the previously investigated Vv2KGR (Burbidge 2011) and the 
Km for L-idonate dehydrogenase of 2.2 mM in the rate-limiting reaction (DeBolt, Cook & 
Ford 2006). This suggests 2KGR2 has a similar affinity for 2-keto-L-gulonate to enzymes 
involved in the TA biosynthesis pathway. 
To identify the products of 2KGR1 and 2KGR2 using 2-keto-L-gulonate as a substrate, an 
in vitro enzyme reaction was performed and the reaction mixture analysed by HPLC 
(Figure 3-8). 2-Keto-L-gulonate and L-idonate were identified based on authentic 
standards. Neither the 2KGR1 nor the 2KGR2 reaction produced a detectable new product 
peak, and the concentration of 2-keto-L-gulonate remained virtually unchanged after two 
hours reaction time. This suggests the 2KGR candidates have low activity against 2-keto-L-
gulonate under the conditions tested. The reaction conditions may need to be optimised 
or performed for a longer amount of time. However, the chosen reaction conditions were 
based on the activity of the previously identified Vv2KGR, so it is expected that the 
candidate 2KGR enzymes would have performed under similar conditions.  
2KGR1 was computationally predicted to be a hydroxyphenylpyruvate reductase, and 
2KGR2 was predicted to be a glyoxylate/hydroxypyruvate reductase (Table 3-2). 
Therefore the activity of these enzymes was tested over a range of substrates found in V. 
vinifera, including glyoxylate. 2KGR1 and 2KGR2 exhibited a similar substrate range, 
showing activity against three out of the four substrates tested (Figure 3-9). Both 2KGR1 
and 2KGR2 showed similar levels of activity against glyoxylate as 2-keto-L-gulonate, and 
approximately 50% lower activity against ascorbate. However, activity levels were low, 
suggesting these enzymes are capable only of low-level reactions, or primary substrate(s) 
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were not tested. Both enzymes were able to utilise ascorbic acid, the tartaric acid 
precursor, as substrate. To investigate if the product of this reaction is a biosynthetic 
precursor of tartaric acid, HPLC could be used to analyse the reaction mixture. The 
observed activity of both 2KGR1 and 2KGR2 against 5-keto-D-gluconate was not 
significant.  
These results suggest both 2KGR1 and 2KGR2 display low activity as 2-keto-L-gulonate 
reductases, but it may not be their primary function. No evidence of L-idonate formation 
was found, indicating that it is unlikely that these 2KGR candidates are involved in the 
ascorbic acid pathway of tartaric acid biosynthesis. Both 2KGR1 and 2KGR2 display low-
level, broad-spectrum reductase activity and may be involved as reductases in other 
metabolic pathways. Further characterisation with a wider range of substrates is required 
to confirm this. However, both 2KGR1 and 2KGR2 were fused with NusA to enhance their 
solubility, which may have affected their catalytic properties. In order to accurately 
characterise the activity of these 2KGRs, it may be necessary to cleave the NusA tag. 
Additionally, reaction conditions may be further optimised. For example, these assays 
were performed at 37 °C based on results from the previously characterised Vv2KGR0, 
but the optimal temperature for the enzymes may in fact be lower, considering they 
originate from a plant which would grow at a lower ambient temperature.  
As neither 2KGR1 nor 2KGR2 were capable of producing large amounts of L-idonate, these 
enzymes were deemed unsuitable for whole-cell biotransformation of 2-keto-L-gulonate 
to L-idonate. A limiting factor in tartaric acid biosynthesis research to date has been the 
limited availability of L-idonate, a key intermediate in the pathway. Whole-cell 
biotransformation of 2-keto-L-gulonate to L-idonate was investigated as an alternative to 
synthetic approaches for the production of L-idonate as 2-keto-L-gulonate is a readily 
available, cheap substrate, and enzymes are able to achieve stereoselective synthesis for 
ease of purification.  Vv2KGR0 was expressed in E. coli BL21 for whole-cell 
biotransformation. Initial attempts revealed the concentration of 2-keto-L-gulonate in the 
reaction mixture did not decrease after 24 hours in both the Vv2KGR0 strain and the no 
plasmid control strain. This was unexpected, as Vv2KGR0 has been shown to have 2-keto-
L-gulonate reductase activity in vitro, and E. coli is capable of metabolising 2-keto-L-
gulonate to a small degree (Yum et al. 1998). It was hypothesised that biocatalysis was 
restricted due to cell permeability limitations. E. coli is a gram-negative bacterium that 
possesses an outer membrane and an inner membrane. While hydrophobic molecules are 
able to diffuse relatively quickly though the outer lipid bilayer, transport of hydrophilic 
molecules is regulated by specific transport proteins on the inner membrane (Neidhardt, 
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Ingraham & Schaechter 1990). Sugars, amino acids, and other small hydrophilic molecules 
essential to growth rely on passage through porins to cross the membrane barrier. These 
channels are lined with positively charged amino acid residues (Nikaido 2001). This may 
present a cell entry challenge for 2-keto-L-gulonate. 
Enhanced cell permeability was attempted using salt stress. Addition of NaCl has 
successfully been used to improve the uptake of crotonobetaine and D(+)‐carnitine, both 
small, charged molecules, by E. coli. Cánovas et al. (2003) found production of L-(-
)carnitine improved with an increase in NaCl in the reaction buffer up to a concentration 
of 0.5 M. However, when transformation of 2-keto-L-gulonate to L-idonate was re-
attempted with the addition 0.25 M NaCl, no improve in substrate uptake was observed 
(Figure 3-10). This suggests that cell permeability may be a significant challenge in the 
whole-cell production of L-idonate from 2-keto-L-gulonate. There are several other 
methods that can be used to enhance cell permeability (Chen 2007). Cells may be treated 
with an organic solvent such as ethanol or toluene, but this can remove endogenous 
cofactor which needs to be re-supplied to the cell. Detergent treatment is another 
approach, but is harsher and may lead to cell lysis. Freeze and thaw is a simple approach 
but time-consuming when multiple cycles are required. Electropermeabilisation may be 
applied to ionic products, but requires specialised equipment. Alternatively, molecular 
engineering approaches may be used to modify the membrane structures or display 
catalysts on the cell surface, circumventing the need for cell entry. These are all viable 
options to enhance 2-keto-L-gulonate cell entry, but the process may require extensive 
optimisation. Once cell entry is achieved, L-idonate production may be further increased 
by knocking out metabolic pathways that consume L-idonate (Bausch et al. 1998) and 
considering in situ cofactor regeneration (Kara, Schrittwieser & Hollmann 2013).  
Another approach could be to use a cell-free system. Although a whole cell system is 
preferred since it circumvents the need for extensive extraction and purification and the 
addition of expensive coenzyme, an in vitro reaction with purified enzyme may be more 
straightforward in this case. Finally, if low yields are experienced using Vv2KGR0, A. niger 
GluD or GluC may be substituted to optimise the reaction. More work is required to 
successfully achieve microbial biosynthesis of L-idonate, but the number of viable avenues 
are plentiful. 
Conclusions 
Two potential V. vinifera 2-keto-L-gulonate reductases were identified based on homology 
to recently characterised A. niger 2-keto-L-gulonate reductases that are able to produce L-
idonate, a key intermediate in tartaric acid biosynthesis. The two 2KGRs were found to 
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have low level activity using 2-keto-L-gulonate as a substrate, but did not produce L-
idonate. These enzymes exhibited low-level broad-spectrum reductase activity, although 
their primary substrate(s) may not have been tested. It is unlikely that these enzymes are 
involved in the biosynthesis of tartaric acid from ascorbate in grapevine.  
Further research into the biosynthesis of tartaric acid in grapevine may be assisted by 
providing access to L-idonate. Whole-cell biotransformation of 2-keto-L-gulonate to L-
idonate may be a viable option for the production and purification of L-idonate, but the 
process requires further testing and optimisation to overcome the challenge of cell entry. 
Alternatively, in vitro production of L-idonate with purified or resin-bound enzyme may 
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Supplementary Figure 3-1 Solubility test for 2KGR1. WC: whole cell samples (insoluble fraction). 1-20 are 
different buffers used to test solubility. 1: 20 mM Tris 8.0, 0.5 M NaCl, 10 mM imidazole, 2mM β-mercaptoethanol 
(BME). 2: 20 mM Tris 8.0, 0.5 M NaCl, 10 mM imidazole, 2mM BME, 1mM zinc sulphate. 3: 20 mM Tris 8.0, 0.5 M 
NaCl, 10 mM imidazole, 2mM BME, 1mM MgCl2 4: 20 mM Tris 8.0, 0.5 M NaCl, 10 mM imidazole, 2mM BME, 1mM 
CaCl2. 5: 20 mM Tris 8.0, 0.5 M NaCl, 10 mM imidazole, 2mM BME, 1mM NADH. 6: 20 mM Tris 8.0, 0.5 M NaCl, 
2mM BME. 7: 20 mM Tris 8.0, 0.5 M NaCl, 15mM BME. 8: 20 mM Tris 8.0, 0.5 M NaCl, 10mM imidazole, 2mM BME, 
20% glycerol. 9: 20 mM Tris 8.0, 0.5 M NaCl, 10mM imidazole, 2mM BME, 10% glycerol. 10: 20 mM HEPES 7.0, 0.5 
M NaCl, 2mM BME. 11: 20 mM Sodium Citrate 5.5, 0.5 M NaCl, 2mM BME. 12: 50 mM Sodium Acetate, 0.5 M NaCl, 
2mM BME. 13: 20 mM Tris 8.0, 0.2 M NaCl, 10 mM imidazole, 2mM BME. 14: 20 mM Tris 8.0, 20 mM NaCl, 10 mM 
imidazole, 2mM BME. 15: 20 mM Tris 8.0, 2mM BME. 16: 100 mM Sodium Phosphate 7.5, 0.5 M NaCl, 10 mM 
imidazole, 2mM BME. 17: 20 mM Tris 8.0, 0.5 M NaCl, 10 mM imidazole, 2mM BME, 0.1% tween. 18: 20 mM Tris 
8.0, 0.5 M NaCl, 10 mM imidazole, 2mM BME, 0.5% sucrose. 19: 20 mM Tris 8.0, 0.5 M NaCl, 10 mM imidazole, 
2mM BME, 0.1 M urea. 20: 50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM imidazole, 15% glycerol. 2KGR1 is 
circled in yellow.  
 





Chapter 4 Production of Grapevine Sesquiterpenes and 
Sesquiterpenoids in Yeast 
Introduction 
Terpenoids are one of the largest classes of plant metabolites and perform many 
ecological roles, including plant defence, attraction of pollinators, and primary plant 
metabolism (Bohlmann & Keeling 2008). Terpenes are biosynthesised from five-carbon 
prenyldiphosphate precursors, and these simple building blocks are transformed into a 
large number of diverse structures through the action of terpene synthases (May, Lange & 
Wüst 2013). The hydrocarbon terpene backbone may be further diversified by the action 
of cytochrome P450 monoxygenases or various transferases (O'Maille et al. 2008).  
Sesquiterpenoids are 15-carbon terpene derivatives that are synthesised by 
sesquiterpene synthases using farnesyl pyrophosphate (FPP) as substrate. Thousands of 
sesquiterpenoids have been identified, although not all have been fully structurally 
elucidated (Duhamel et al. 2018). Sesquiterpenoids are important contributors to the 
flavour and aroma of many plants (Dudareva & Pichersky 2000, 2006). A wide variety of 
sesquiterpenoids have been identified in grapevine (Vitis vinifera) and wine (Coelho et al. 
2006; Schreier, Drawert & Junker 1976). However, the contributions of many of these 
compounds to the aroma and character of wine are as yet unrecognised. The exception is 
rotundone, a sesquiterpene ketone derived from α-guaiene, which has a potent spicy, 
peppery aroma, and has been found in some cultivars of Shiraz and several other varieties 
(Wood et al. 2008). Additionally, there has been recent interest in the potential health 
benefits of wines containing sesquiterpenoids (Rocha et al. 2006; Vinholes 2013). The 
immense structural diversity of sesquiterpenoids and their unique properties suggest 
there is more to be learned about sesquiterpenoids in grapes and wine.  
A number of V. vinifera sesquiterpene synthases have been previously identified through 
genome mining and transcriptome analysis (Martin et al. 2010; Martin et al. 2012; 
Sweetman et al. 2012); however, not all have been characterised in vivo. Previous 
investigations have shown that occasionally sesquiterpene synthases may produce 
different products in vitro than in vivo (Salvagnin et al. 2016), so it is important to use a 
number of systems to accurately characterise these enzymes. By characterising the 
products of grapevine sesquiterpene synthases it may be easier to identify 
sesquiterpenoids in wine. 
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However, in planta characterisation requires skill, time and resources to create and grow 
transgenic plants, and sensitive analysis techniques to separate and identify 
sesquiterpenoids amongst other plant metabolites. An alternative is to use a microbial 
expression system that is able to produce the sesquiterpene precursor FPP, and 
overexpress the sesquiterpene synthase of interest. The advantages of using microbial 
biosynthesis are a greater concentration of product, allowing facile analysis and 
identification, and rapid investigation, allowing a number of enzymes to be analysed and 
compared. Furthermore, the cellular milieu mimics the native protein environment, 
making the results more applicable to in planta conditions than in vitro experiments using 
recombinant protein. EPY300 is a yeast strain based on the Saccharomyces cerevisiae 
strain S228C that has been genetically engineered to overproduce FPP (Ro et al. 2006). 
This strain may be used to express sesquiterpene synthases and is capable of product 
titres in the range of several mg/L in optimised strains (Rodriguez et al. 2014). This 
platform allows co-expression of P450 monooxygenases capable of modifying the 
sesquiterpene hydrocarbon backbone. Investigation of grapevine sesquiterpene synthases 
using microbial systems in conjunction with P450s may lead to the discovery of new 
products and novel wine aroma compounds. 
The aim of this study was to investigate and identify products of six grapevine 
sesquiterpene synthases and their potential oxygenated derivatives. To achieve this, the 
sesquiterpene synthase genes were expressed in EPY300 alongside P450BM3. P450BM3 is 
unusual within the P450 family as it is fused with a reductase, negating the need to 
express an additional, third enzyme and increasing the catalytic efficiency of the P450 
(Govindaraj & Poulos 1995; Nguyen, MacNevin & Ro 2012). A mutant P450BM3 was used as 
it is a promiscuous enzyme that can modify many substrates and may assist in identifying 
sesquiterpenoids able to be produced in planta by grapevine P450s. 
Results 
Six sesquiterpene synthases were cloned from Vitis vinifera cv. Shiraz for use in this study 
(Table 4-1). To identify products of the sesquiterpene synthases and investigate the 
reactivity of the mutant P450BM3 with those products, each sesquiterpene synthase was 
expressed in EPY300 yeast with either the mutant P450BM3, or the wild-type P450BM3 as a 
control. The empty pESC-Leu2d vector and vectors containing only the wild-type P450BM3 




Table 4-1 Accession numbers of genes characterised in this study. 
Gene Accession # Functional Gene ID 
TPS07 HM807377 VvGwGerD 
TPS24 XM_002282452 VvGuaS 
TPS26 HM807407 VvPNCuCad 
TPS27 HM807374 VvGwECar2 
TPSY1 XM_003634648.1  
TPSY2 XM_002263544.2  
 
Sesquiterpenes were identified in the yeast culture organic extracts by GC-MS analysis. 
Although the concentrations of sesquiterpenoids in samples were relatively low, 
chromatography showed clear separation and sharp peaks. Total Ion Chromatograms 
(TIC) of sample extracts were compared to control extracts to identify compounds unique 
to the sample culture (Figure 4-1). All sample TICs are available in Supplementary 
Figures. 
 
Figure 4-1 Total Ion Chromatograms (TIC) of empty vector (top) and P450BM3 mutant only (second from top) 
culture extracts compared to sample culture extracts (second from bottom and bottom). The comparison reveals 
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unique products that are present in the sample culture extracts. Chromatography showed good separation and 
sharp peaks.   
Sesquiterpenoid compounds were identified by comparison of the mass spectra to the 
National Institute of Standards and Technology (NIST) library using NIST MS Search 2.2.  
The NIST match factors and probability values were used to assess library hit results. In 
general, a value of 900 or greater is considered an excellent match and 800-900 a good 
match (NIST Standard Reference Database 1A User's Guide  2008). Match factor values are 
given in brackets after the name of the library match compound.  
The major product of TPS07 was germacrene D, but cadinene-type structures and 
caryophyllene-type structures were also identified (Table 4-2). Several sesquiterpene 
oxides present in the sample were not found in the NIST library, including one product 
produced only by the P450BM3 mutant.  
Table 4-2 Sesquiterpenoid products of EPY300 expressing TPS07. The NIST match values for library compounds 
are given in brackets. 
Retention Time (min) Sample Library Match 
14.34 BM3 Wild Type and BM3 
Mutant 
germacrene D (916); 
isogermacrene D (880) 
17.70 BM3 Wild Type and BM3 
Mutant 
α-cadinol (909) 
19.72 BM3 Wild Type and BM3 
Mutant 
C15H24O 
20.03 BM3 Mutant only C15H24O 
20.48 BM3 Wild Type and BM3 
Mutant 
caryophyllene oxide-
like1  C15H24O 
 
α-Bisabolol was identified in the TPS24 sample. (Table 4-3). Pogostol was produced by 
the P450BM3 mutant.  
Table 4-3 Sesquiterpenoid products of EPY300 expressing TPS24. The NIST match values for library compounds 
are given in brackets. 
Retention Time (min) Sample Library Match 
17.72 BM3 Mutant only pogostol (842) 




TPS24 has been previously characterised as a guaiene synthase (Drew et al. 2016). 
However, neither α-guaiene nor δ-guaiene were found in the sample. As these are volatile 
                                                             
1 ‘Caryophyllene oxide-like’ refers to a compound that shares similar mass spectral features to 
caryophyllene oxide but is not a close enough match to any compound in the NIST library to be 
positively identified. Due to the similarity in the mass spectra, it is likely these compounds contain 
similar substructures as caryophyllene oxide.  
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sesquiterpenoids, EPY300 culture was repeated using a dodecane overlay (10% of culture 
volume) to trap volatile compounds. α-Guaiene, δ-guaiene, and a third guaiene-like 
sesquiterpene were present in the sample, as well as pogostol and α-bisabolol, which 
were identified in the non-dodecane overlayed culture (Table 4-4). 
 
Table 4-4 Sesquiterpenoid products of dodecane overlay from culture of EPY300 expressing TPS24. The NIST 
match values for library compounds are given in brackets. 
Retention Time (min) Sample Library Match 
14.74 BM3 Wild Type and BM3 
Mutant 
α-guaiene (951) 
15.68 BM3 Wild Type and BM3 
Mutant 
δ-guaiene (940) 
15.88 BM3 Mutant only guaiene-like C15H24 
17.72 BM3 Mutant only pogostol (909) 




TPS26 produced mainly cadinene and cubebene-type structures, with two unidentified 
oxygenated sesquiterpenoids present in the mutant P450BM3 extract (Table 4-5).  
Table 4-5 Sesquiterpenoid products of EPY300 expressing TPS26. The NIST match values for library compounds 
are given in brackets. 
Retention Time (min) Sample Library Match 
15.76 BM3 Wild Type and BM3 
Mutant 
δ-cadinene (905) 
16.10 BM3 Mutant only C15H24O 




17.54 BM3 Wild Type and BM3 
Mutant 
epicubenol (924) 
17.70 BM3 Wild Type and BM3 
Mutant 
α-cadinol (930) 
22.20 BM3 Mutant only C15H24O2 
 
TPS27 produced predominantly caryophyllene-like structures and α-cadionol (Table 4-6). 
The P450BM3 mutant produced four oxygenated sesquiterpenoids.  
Table 4-6 Sesquiterpenoid products of EPY300 expressing TPS27. The NIST match values for library compounds 
are given in brackets. 
Retention Time (min) Sample Library Match 
14.20 BM3 Wild Type and BM3 
Mutant 
β-caryophyllene (955) 





17.70 BM3 Wild Type and BM3 
Mutant 
α-cadinol (907) 
19.82 BM3 Mutant only caryophyllene oxide-
like C15H24O 
20.01 BM3 Mutant only C15H24O 
20.69 BM3 Mutant only clovanediol-like 
C15H26O2 
21.38 BM3 Mutant only caryophyllene oxide-
like C15H24O 
 
To confirm the identity of the peaks at 14.20 min and 14.73 min, authentic standards of β-
caryophyllene and α-caryophyllene were analysed using the same GC-MS method. The 
elution times of these compounds and the mass spectra matched those of the peaks at 
14.20 min and 14.73 min respectively (Supplementary Information).  
To investigate whether the subsequent peaks were products of the sesquiterpene 
synthase or the result of caryophyllene oxidation, cultures of EPY300 expressing P450BM3 
were spiked with 0.5 μg/mL α-caryophyllene or β-caryophyllene. This produced a 
number of caryophyllene oxide derivatives, many of which were not present in the TPS27 
sample in significant concentrations (Figure 4-2).  
 
 
Figure 4-2 Overlay of gas chromatogram culture extract from EPY300 expressing BM3 spiked with α-
caryophyllene (black) and β-caryophyllene (blue) 
The compounds present at 17.70 min, 20.01 min 20.69 min and 21.38 min were not found 
in either the α-caryophyllene- nor β-caryophyllene-spiked samples. A peak at 19.82 min 
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was present in the β-caryophyllene-spiked sample. The mass spectra of the peaks at 19.82 
min in the β-caryophyllene-spiked sample and the TPS27 sample were found to share 
significant similarities (Figure 4-3). 
 
 
Figure 4-3 Comparison of mass spectra at 19.82 min from the extract of EPY300 expressing Mutant P450BM3 
spiked with β-caryophyllene (a) and the extract of EPY300 expressing TPS27 with Mutant P450BM3 (b). 
TPSY1 produced a range of structurally varied compounds, including cubebene-like, 
germacrene-like and cadinene-like sesquiterpenoids (Table 4-7). All compounds were 
found in both the mutant P450BM3 and wild-type P450BM3 extracts.  
Table 4-7 Sesquiterpenoid products of EPY300 expressing TPSY1. The NIST match values for library compounds 
are given in brackets. 
Retention Time (min) Sample Library Match 
14.16 BM3 Wild Type and BM3 
Mutant 
β-ylangene (896) 




14.58 BM3 Wild Type and BM3 
Mutant 
isogermacrene D (882) 




15.15 BM3 Wild Type and BM3 
Mutant 
germacrene D (936) 
15.77 BM3 Wild Type and BM3 
Mutant 
δ-cadinene (883) 
17.25 BM3 Wild Type and BM3 
Mutant 
juneol (923) 
17.52 BM3 Wild Type and BM3 
Mutant 
α-cadinol-like C15H26O 














TPSY2 also produced a range of compounds including caryophyllenes, cadinene and 
cubenols (Table 4-8). All compounds were present in both the mutant P450BM3 and wild-
type P450BM3 extracts. 
Table 4-8 Sesquiterpenoid products of EPY300 expressing TPSY2. The NIST match values for library compounds 
are given in brackets. 
Retention Time (min) Sample Library Match 





14.73 BM3 Wild Type and BM3 
Mutant 
α-caryophyllene (942) 
15.75 BM3 Wild Type and BM3 
Mutant 
δ-cadinene (923) 









In this study, the products of several Vitis vinifera sesquiterpene synthases and their 
derivatives were investigated and identified using a yeast in vitro assay. A promiscuous 
P450, P450BM3, was included to identify oxygenated derivatives of the sesquiterpene 
synthase products. This may provide insight into sesquiterpenoids that can be produced 
through oxidation in planta by grapevine P450s. A wild-type, non-promiscuous P450BM3 
was used as a control. Since wild-type P450BM3 is selective, the compounds produced by 
the sesquiterpene synthases are not expected to be oxidised, so the products would be 
essentially the same as if the sesquiterpene synthases were expressed without a P450. 
The aim of the study was to investigate and identify products of six sesquiterpene 
synthases and their potential oxygenated derivatives.  
Previous studies have shown that using the metabolically engineered EPY300 yeast strain 
with the high-copy pESC Leu2d plasmid can produce significant amounts of 
sesquiterpenes and oxygenated sesquiterpenes, although yield can vary dramatically 
(Nguyen, MacNevin & Ro 2012). Here, the engineered EPY300 strain was able to produce 
sesquiterpenes in detectable amounts, but the yield was relatively low. Previously, 
EPY300 cultures have been overlayed with dodecane to capture volatile sesquiterpene 
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hydrocarbons(Rodriguez et al. 2014), but in this study a dodecane overlay was not used 
for every sample as it has been observed to interfere with the production of oxygenated 
sesquiterpenoids (Nguyen, MacNevin & Ro 2012). This may have led to the loss of volatile 
sesquiterpenes and decreased the product yield. If this method were to be used for the 
production and purification of sesquiterpenoids on a large scale, modifications could be 
made to improve the yield. Codon-optimisation or protein modifications could be made to 
improve the expression and stability of the sesquiterpene synthase in yeast. Rich media 
(YPD) may be used in place of synthetic media, which would increase the rate of cell 
growth and metabolism, but could lead to plasmid loss over time due to lack of selection 
pressure (Nguyen, MacNevin & Ro 2012). Alternatively, sesquiterpene synthase genes 
could be genomically integrated. This would reduce the gene copy number but increase 
stability and allow for the engineering of highly-stable, productive, sesquiterpenoid cell 
factories. Nevertheless, using the current method, sufficient amounts of product were 
present in the extracts to enable GC-MS analysis and identification with a good signal-to-
noise ratio (Supplementary Figures). 
The NIST library was used to identify sesquiterpenoids based on their mass spectra (MS). 
The search compares the mass spectrum of the unknown compound to compounds in the 
NIST library and assigns a match score based on how closely the mass-to-charge ratios 
and relative abundance of each peak are related. A score of 1000 correlates to a perfect 
match, ranging to zero for nothing in common (Stein 1994). In general, a value of 900 or 
greater is considered an excellent match, 800-900 a good match, 700–800 a fair match 
and less than 600 a very poor match. Each match is also assigned a probability value 
which estimates the probability that the match is correct, based on the similarity of the 
other matches in the hit list and the probability of the unknown compound existing in the 
library (NIST Standard Reference Database 1A User's Guide  2008; Stein 1994).  
The match value and probability value were used to assess the library hit results. Match 
values over 900 generally indicate a positive hit, and it is possible to be confident in the 
result. However, compounds listed with match values under 900 did show noticeable 
differences between the unknown MS and the library MS (e.g. Supplementary Figure 4-5). 
It is possible that compounds with match values less than 900 are very similar to the 
library match but vary slightly in their structure. Currently there are 191,436 spectra in 
the main library (NIST Standard Reference Database 1A User's Guide  2008). Due to the size 
of the library, it provides a good basis for the identification of common compounds, but is 
not an exhaustive list, so some compounds remain unidentified. Furthermore, retention 
times were not taken into account for product identification, as they vary depending on 
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the experiment set up. Overall, the library is a useful tool that can lead to the positive 
identification of common products and closely-related structures but should be used with 
caution.  
TPS07 produced germacrene D, with cadinene-type structures and caryophyllene-type 
structures also present (Table 4-2). TPS07 is similar to VvGwGerD, which has been shown 
to produce germacrene D as a major product and δ-cadinene as a minor product (8%) in 
vitro (Lücker, Bowen & Bohlmann 2004; Martin et al. 2010). This confirms that 
germacrene D is likely correctly identified in the sample, and supports the presence of 
cadinene-type structures. The caryophyllene-type structure is likely not correctly 
identified as it is not consistent with previously identified products of TPS07, and the true 
structure may be a germacrene D or cadinene derivative with formula C15H24O (MW 220). 
Two other sesquiterpenoid compounds with MW 220 and formula C15H24O were also 
present in the extract but no corresponding library structure was found. Substructures 
identified on the basis of the MS fragmentation pattern suggest these compounds may be 
epoxide derivatives of germacrene D or δ-cadinene. Compounds with similar MW and 
retention times were also identified in the TPSY1 extract. 
TPS24 produced α-bisabolol. The mutant P450BM3 produced pogostol and a second 
unidentified product with formula C15H26O. TPS24 has two known alleles with distinct 
product profiles: VvPNSeInt and VvGuaS (Drew et al. 2016). VvPNSeInt has been shown to 
produce δ-selinene, selinene-type products, intermedeol and α-guaiene in vivo in 
metabolically engineered E. coli (Martin et al. 2010). VvGuaS expressed in Nicotiana 
benthamiana leaves produced α-guaiene and δ-guaiene as its major products, with several 
minor products, including pogostol (3%). The TPS24 allele used for this study was VvGuaS 
cloned from Shiraz; however, neither α-guaiene nor δ-guaiene were detected in the TPS24 
sample extract. This could be due to a number of reasons. Firstly, a dodecane overlay was 
not used initially on the yeast culture, so α-guaiene and δ-guaiene, being volatile 
sesquiterpene hydrocarbons, may have evaporated from the sample. Secondly, TPS24 
may have low activity in EPY300.The gene was not codon-optimised for yeast so it may 
have low levels of expression, resulting in low and undetectable product concentrations. 
However, the presence of pogostol in the mutant P450BM3 sample suggests the existence of 
other compounds with 5,7-bicyclic ring structures. Pogostol is likely a derivative of delta 
guaiene, given their structural similarity, (Figure 4-4). This suggests δ-guaiene present in 
the culture may have been oxidised by P450BM3 to pogostol, a more hydrophilic and less 
volatile compound that would not have escaped from the culture solution as easily. This 
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could be confirmed by feeding EPY300 expressing P450BM3 only with δ-guaiene to 
determine if pogostol is produced by the P450.  
To test whether α-guaiene and δ-guaiene had evaporated from the sample, culture of 
EPY300 expressing TPS24 was repeated using a layer of dodecane over the aqueous 
culture media in order to trap volatile sesquiterpenes. The dodecane was analysed by GC-
MS using the same method as the culture extracts. Pogostol at 17.72 min and α-bisabolol 
at 18.06 min were present in the dodecane overlay, which is consistent with the data from 
the TPS24 culture extract. Importantly, α-guaiene and δ-guaiene were both present in the 
dodecane overlay. This confirms that these volatile sesquiterpenes were produced but 
had escaped from culture and is consistent with the previous characterisation of TPS24 
(Drew et al. 2016). Additionally, a third guaiene-like sesquiterpenoid was present at 15.68 
min. However, rotundone, the pepper aroma compound formed by oxidation of α-guaiene 
(Huang et al. 2014) was not present in the sample, which suggests either α-guaiene was 
sequestered from the yeast culture before oxidation could occur or P450BM3 is unable to 
oxidise α-guaiene to rotundone.  
The presence of α-bisabolol is surprising, as it is not structurally related to the expected 
products, which all share a 5,7-bicyclic ring. The match score for the MS spectrum of the 
peak at 18.06 min with α-bisabolol was 922, which is considered an excellent match, and 
the mass spectra are nearly identical (Supplementary Figures). This indicates there is a 
high probability that the unknown compound is α-bisabolol, but considering that α-
bisabolol has never been previously found among products of TPS24 and does not share 
structural properties with other products of TPS24, more conclusive evidence is required. 
The unknown product could be a novel product that is similar to α-bisabolol but not 
present in the library. The mass spectrum of the unknown product does not match that of 
rotundol or any downstream products from the aerial oxidation of α-guaiene (Huang et al. 
2015). In order to confirm the identity of the product, a standard of α-bisabolol could be 
run using the same GC-MS protocol to confirm that the retention time matches that of the 
unknown product. Alternatively, the yeast culture volume could be scaled up and the 





Figure 4-4 α-Bisabolol and Pogostol were present in extracts of EPY300 expressing TPS24. α-Guaiene and δ-
Guaiene were expected products of TPS24 but were not found in the extract.  
TPS26 produced δ-cadinene, di-epi-1,10-cubenol, epicubenol and α-cadionol. The mutant 
P450BM3 also produced two unidentified sesquiterpenoid derivatives (Table 4-5). TPS26 
(functional gene ID VvPNCuCad) has previously been characterised in vivo using 
metabolically engineered E. coli and was found to be a Cubebol/δ-Cadinene synthase with 
major products cubebol, δ-cadinene, α-cubebene, α-copaene, α-gurjunene, γ-cadinene and 
β-cubebene (Martin et al. 2010). This is consistent with the observed production of δ-
cadinene and cadinene and cubebene derivatives. Again, not all of the previously 
identified products of TPS26 were found in the yeast culture extract, and this could be due 
to loss of volatile sesquiterpene hydrocarbons from the culture. All of the products that 
were identified in the TPS26 yeast culture extract had match factors greater than 900, 
indicating an excellent match with the library compound. Given the high match factors 
and the consistency with previous results, it is highly likely that these products have been 
correctly identified. The products identified in the yeast culture extract show many 
structural similarities (Figure 4-5). All share a 6,6-bicyclic ring structure with 1-isopropyl 
and 4,7-dimethyl groups.  The structural similarities suggest that the products are formed 
by a common, non-enantioselective mechanism (Yoshikuni, Ferrin & Keasling 2006).  
The unidentified sesquiterpenoids produced by P450BM3 were not found in any of the 
other samples. The two products have molecular formulas of C15H24O (MW 220) and 
C15H24O2 (MW 236) respectively. These unidentified products are likely singly- and 
doubly- oxygenated derivatives of δ-cadinene or cubebene. The double oxygenation of the 
unknown compound at 22.20 min also explains its unusually long retention time, as this 




Figure 4-5 Products of TPS26 share structural similarities. 
TPS27 produced β-caryophyllene, α-caryophyllene (α-humulene) and α-cadinol. Co-
expression of TPS27 and the mutant P450BM3 resulted in the formation of three additional, 
unidentified sesquiterpenoid products (Table 4-6).  Standards of β-caryophyllene and α-
caryophyllene are both commercially available, so these were compared to the sample 
peaks. The elution times of and mass spectra of the standards matched those of the 
sample peaks at 14.20 min and 14.73 min respectively. This indicates that NIST library 
comparison was able to be used to accurately identify these compounds, and justifies the 
use of this method for other compounds for which standards are not so readily available.  
TPS27 (functional gene ID VvGwECar2) has previously been functionally characterised 
both in vitro by feeding recombinant protein with farnesyl pyrophosphate (FPP) as 
substrate and in planta in both transgenic Arabidopsis thaliana and grapevine. In vitro, 
TPS27 catalysed the cyclisation of FPP to produce β-caryophyllene, α-caryophyllene and a 
small amount of germacrene D (Martin et al. 2010; Matarese et al. 2014). Expressed in A. 
thaliana, TPS27 produced β-caryophyllene, α-caryophyllene and thujopsene, but no 
germacrene D was detected. Thujopsene appears to be a by-product of the enzyme 
outside the homologous expression system as only β-caryophyllene and α-caryophyllene 
were detected when TPS27 was overexpressed in V. vinifera (Matarese et al. 2014). These 
results are consistent with the identification of β-caryophyllene and α-caryophyllene 
within the TPS26 yeast culture extract and suggest that the production of α-cadinol may 
be an artefact of the expression system for this particular enzyme. The presence of α-
cadinol is unexpected as it does not share similar structural properties with β-
caryophyllene and α-caryophyllene, but interestingly it does share a 6,6-bicyclic ring 




Figure 4-6 Products of TPS27. Thujopsene and α-cadinol share structural similarities but are not closely 
structurally related to β-caryophyllene and α-caryophyllene. 
Co-expression of the mutant P450BM3 led to the formation of four additional products. The 
product at 20.69 min had a molecular formula of C15H26O2 (MW 238). The closest library 
match was clovanediol, which was a good match (match factor 800-900), but not identical. 
This suggests the compound may share some features in common with clovanediol, but it 
is not an exact match. Similarly, the product at 21.38 min had a molecular formula of 
C15H24O (MW 220) and was a good match, but not identical, to caryophyllene oxide. 
Caryophyllene oxide would be an expected product of β-caryophyllene oxidation, so it is 
possible that the unknown compound is very similar to caryophyllene oxide.  
To investigate the origin of these products, EPY300 expressing the mutant P450BM3 only 
was cultured with either β-caryophyllene or α-caryophyllene in order to identify which 
peaks arise as the result of the presence of either β-caryophyllene or α-caryophyllene. GC-
MS analysis of both β-caryophyllene and α-caryophyllene culture extracts revealed a 
number of peaks not present in the TPS27 culture. These appear to be caryophyllene 
oxides and epoxides formed by providing P450BM3 with a high concentration of substrate. 
The compounds present at 17.70 min, 20.01 min 20.69 min and 21.38 min were not found 
in either of the caryophyllene-spiked samples. Since α-cadinol (17.70 min) was found in 
both the BM3 Wild Type and BM3 Mutant culture extracts, it is likely to be a direct 
product of TPS27. The compounds at 20.01 min 20.69 min and 21.38 min were only found 
in the BM3 Mutant samples and not in either of the caryophyllene-spiked samples, so they 
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may be P450BM3-oxygenated derivatives of α-cadinol. To confirm this, EPY300 expressing 
the mutant P450BM3 only could be cultured with α-cadinol in a similar way to the 
caryophyllene experiments.  
 A peak at 19.82 min was present in the β-caryophyllene-spiked sample. The mass spectra 
of the peaks at 19.82 min in the β-caryophyllene-spiked sample and the TPS27 sample 
were found to share significant similarities, so this is likely to be the same compound 
(Figure 4-3). This indicates the caryophyllene-oxide like compound at 19.82 min is a β-
caryophyllene derivative. However, conclusive structural characterisation of the product 
would require NMR spectroscopy of the purified compound since no library match is 
available.  
TPSY1 produced a range of structurally varied products, including β-ylangene, β-
cubebene or β-copaene, isogermacrene D, germacrene D, δ-cadinene, juneol, α-cadinol 
and germacrene-like and cadinene-like oxygenated sesquiterpenoids (Table 4-7). Broadly, 
these can be classified as germacrene-like structures and structures containing 6,6-
bicyclic rings (Figure 4-7). It is likely that these products are formed through a common 
mechanism via germacrene D (Bülow & König 2000; López-Gallego, Wawrzyn & Schmidt-
Dannert 2010).  
 
Figure 4-7 Products of TPSY1 
The peaks at 20.02 min and 20.47 min, corresponding to oxygenated sesquiterpenoids, 
match the retention times of peaks present in the TPS07 sample. Comparison of the mass 
spectra between the TPS07 and TPSY1 samples reveal these products are likely the same 
in both samples (Figure 4-8). These peaks do not have a close library match but are 
suggested to be caryophyllene-oxide or aromadendrene-oxide like with molecular 
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formula C15H24O. Since TPS07 is a germacrene D synthase, and germacrene D is also 
produced by TPSY1, it is hypothesised that both compounds are germacrene D mono-
oxygenated derivatives. Substructure reports suggest these compounds are epoxides of 
germacrene D.  
 
Figure 4-8 The mass spectra of peaks found in the TPS07 extract match those of peaks found in the TPSY1 extract 
TPSY1 has not been previously characterised; however, transcriptome analysis shows it is 
only expressed in young berries (3-weeks post anthesis) in Vitis vinifera cv. Shiraz 
(Sweetman et al. 2012). Of the products identified in the TPSY1 yeast culture extract, δ-
cadinene is the only one that has been identified so far in young berries (4-weeks post 
anthesis) (Zhang et al. 2016a). The other products found in the TPSY1 yeast culture 
extract may not have been detected in grapes previously due to low concentrations or 
because they are not major products, compared to the abundance of more common 
sesquiterpenes like δ-cadinene. It is reasonable to conclude that these products have been 
accurately identified due to their high library match factors (>900). Furthermore, the 
structural similarity of the products means it was reasonable that they were synthesised 
by the same enzyme. Nevertheless, further characterisation of TPSY1 is required to 
confirm these products are produced in vitro by the enzyme using FPP as a substrate and 
in planta in an overexpression system to determine whether these products can be found 
in grapevine tissues.  
TPSY2 produced β-caryophyllene/isocaryophyllene, α-caryophyllene, δ-cadinene, di-epi-
1,10-cubenol and epicubenol. All of the products of TPSY2 could be confidently identified 
using the NIST library, with every compound having a match factor over 900. The identity 
of the product at 14.18 min was ambiguous between β-caryophyllene and 
isocaryophyllene, as both had high match factors and almost identical structures (Figure 
4-9). The products of TPSY2 have not been previously characterised. Like TPSY1, it is 
expressed in V. vinifera cv. Shiraz exclusively at the young berry stage(Sweetman et al. 
2012). β-Caryophyllene, α-caryophyllene, δ-cadinene, and epicubenol have all been 
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identified in extracts of young berries (4 weeks post anthesis) (Zhang et al. 2016a). 
Therefore, it is reasonable to conclude this is likely an accurate characterisation of the 
TPSY2 products.  
 
Figure 4-9 Products of TPSY2 
TPSY2 shares products in common with both TPS26 (δ-cadinene, di-epi-1,10-cubenol, 
epicubenol) and TPS27 (β-caryophyllene, α-caryophyllene). TPSY2 shares 58.9% 
sequence identity with TPS26 and 70.9% sequence identity with TPS27 at the amino acid 
level. The similarities in amino acid sequence may account for the common products. 
Additionally, β-caryophyllene is involved in chemical defence and is biologically active 
against the pest European Grapevine Moth (Lobesia botrana) (Tasin et al. 2005). 
Therefore, expressing multiple β-caryophyllene synthases may be advantageous to the 
plant.  
The six sesquiterpene synthase expression systems produced a large number of 
structurally varied sesquiterpenoids. In total, seventeen unique sesquiterpenoids were 
confidently identified as products of the six sesquiterpene synthases. Additionally, a 
number of sesquiterpene hydrocarbons acted as substrates for P450BM3; however, many 
of these products were not positively identified due to the limitations of the available 
library. Oxygenation can change the biological properties of sesquiterpenes. For example, 
valencene is a sesquiterpene hydrocarbon with an orange-citrus aroma. Oxidation to a 
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ketone yields nootkatone, which has a distinctive grapefruit aroma (Hunter & Brogden JR. 
1965). Another sesquiterpene hydrocarbon, α-guaiene, has a woody, balsamic aroma 
(Acree & Arn 2004), and may be oxidised to rotundone, which is responsible for the 
peppery character of some wines (Wood et al. 2008). Therefore, further investigation into 
identifying the origins and the structures of these oxygenated sesquiterpenoids may 
provide insight into the flavour or aroma of wine. This may include gas chromatography 
analysis with olfactometric detection (GC-O) to investigate whether these oxygenated 
sesquiterpenoids have detectable aromas, or large-scale culture and purification to 
positively identify the products by NMR.  
Most of the sesquiterpene synthases produced multiple products, and several had 
products in common. Terpenoids are important in nature as they perform a multitude of 
ecological roles including direct defence against pathogens and pests (Heiling et al. 2010), 
attraction of pollinators (Dudareva & Pichersky 2000), and signals for plant-plant 
communication (Arimura et al. 2000). The core active site of sesquiterpene synthases is 
preserved across the greater family of terpene synthases, with the active site cavity acting 
as a template for FPP binding (Lesburg et al. 1997). It is thought that sesquiterpene 
synthases evolved from a common, promiscuous ancestor and have the ability to adopt 
novel or altered functions via a few amino acid substitutions (Yoshikuni, Ferrin & Keasling 
2006). Phylogenetic analysis suggests that most grapevine sesquiterpene synthases form 
clusters of paralogous genes that have arisen due to gene duplications (Martin et al. 
2010). This accounts for the product commonality between the sesquiterpene synthases. 
Product diversity can arise from a small number of amino acid substitutions (Drew et al. 
2016), and given the wide range of ecological activities of sesquiterpenoids, product 
diversity is likely to confer an evolutionary advantage to the organism.  
Sesquiterpenoids are also highly valuable to humans as fragrances and flavours, and may 
have medicinal benefits (Babalola, Anetor & Adeniyi 2001; Bohlmann & Keeling 2008). 
Sesquiterpenoids are important for the aroma and character of wine (Mayr et al. 2014; 
Wood et al. 2008), and recent research has explored the potential health benefits of wines 
containing sesquiterpenoid compounds (Duhamel et al. 2018). Several of the 
sesquiterpenoids identified in the EPY300 culture extracts have distinctive aromas or 




Table 4-9 Many of the sesquiterpenoids found in the yeast culture extracts have distinctive aromas or bioactivity 
Sesquiterpenoid Aroma Bioactivity 
Germacrene D wood, spice1  
δ-Cadinene thyme, medicine, wood1  
Caryophyllene 
Oxide 
herb, sweet, spice1 analgesic, anti-inflammatory2, 
preservative, anti-fungal3 
Pogostol  anti-emetic4 
α-Bisabolol spice, flower1 wound healing5 ,anti-microbial6, 
anti-proliferative7    
α-Cadinol herb, wood1 anti-mite8 
Epicubenol spice, herb, green tea1  
β-Caryophyllene wood, spice1 targets CB2 receptor of 
endocannabinoid system, anti-
anxiety, anti-depressant 9, analgesic 
10, local anaesthetic 11 
α-Caryophyllene wood1 anti-inflammatory12, cytotoxic13 
β-Cubebene citrus, fruit1  
1 (Acree & Arn 2004), 2 (Chavan, Wakte & Shinde 2010), 3 (Yang, D et al. 2000), 4 (Yang, Y et al. 1999), 5 
(Villegas et al. 2001), 6 (Forrer et al. 2013), 7 (Mendes et al. 2017), 8 (Chang et al. 2001), 9  (Bahi et al. 2014), 10 
(Klauke et al. 2014),  11 (Ghelardini et al. 2001) 12 (Fernandes et al. 2007), 13 (Legault et al. 2003) 
Many of the sesquiterpenoid products identified in the EPY300 culture extracts have been 
described in the viticulture and oenology literature (Schreier, Drawert & Junker 1976; 
Zhang et al. 2016b). However, the effect of some compounds on wine aroma and character 
have not been studied. Given the range of compounds and variety of aromas, the products 
of the terpene synthases studied may contribute significantly to wine character and 
quality. Furthermore, a number of these compounds show beneficial bioactivities, which 
can serve as a marketing platform for wines containing sesquiterpenoids. The molecules 
identified in this work may serve as a useful reference framework for future studies into 
wine composition, aroma, and health benefits.  
Conclusions 
A number of sesquiterpenes and oxygenated derivatives were identified as products of 
the six V. vinifera sesquiterpene synthases investigated in this study. This demonstrates 
the diversity of sesquiterpene synthases and sesquiterpenoid products that may be found 
in grapes and wine. This work may be used as a platform for further identification of 
sesquiterpenoids and investigation into their contributions to the flavour, aroma and 
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GC-MS Data for TPS07 
 
 
Supplementary Figure 4-1 Total Ion Chromatogram (TIC) of extract from EPY300 expressing TPS07 with Mutant 
P450BM3 (blue) overlayed with TIC of extract from the Mutant P450BM3 only control (black). New peaks are 
present at 14.19 min and 14.34 min. 
  



















Supplementary Figure 4-2 TIC of extract from EPY300 expressing TPS07 with Mutant P450BM3 (blue) overlayed 
with TIC of extract from the Mutant P450BM3 only control (black). New peaks are present at 20.03 min and 20.48 
min. 
 
Supplementary Figure 4-3 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing TPS07 
with Mutant P450BM3 at 14.34 min (red) with the library spectrum of Germacrene D (blue). 
 













Scan 889 (14.338 min): 2MUT.D\ data.ms (-885) Germacrene DHead to Tail MF=871 RMF=928
































Supplementary Figure 4-4 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing TPS07 
with Mutant P450BM3 at 17.70 min (red) with the library spectrum of α-cadinol.(blue). 
 
 
Supplementary Figure 4-5 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing TPS07 
with Mutant P450BM3 at 20.48 min (red) with the library spectrum of caryophyllene oxide (blue).  
 




Supplementary Figure 4-7 Mass spectra from the extract of EPY300 expressing TPS07 with Mutant P450BM3 at 
20.03 min.
Scan 1212 (17.699 min): 2WT.D\ data.ms (-1210) α-CadinolHead to Tail MF=824 RMF=854


































234 245 254 264 275 302 312 324 333 343 356 370 385 401 412 422 434 479 498
Scan 1479 (20.477 min): 2MUT.D\ data.ms (-1482) Caryophyllene oxideHead to Tail MF=800 RMF=820



























233 245 260 273 314 328 341 366 380 398 413 432 445 461 475
(Text File) Scan 1405 (19.707 min): 2MUT.D\ data.ms (-1399)












135 147 158 171 183 195 208 222 233 246 259 271 283 326 354 401 415 441
(Text File) Scan 1436 (20.030 min): 2MUT.D\ data.ms (-1445)
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GC-MS Data for TPS24 
 
Supplementary Figure 4-8 TIC of extract from EPY300 expressing TPS24 with Mutant P450BM3 (blue) overlayed 
with TIC of extract from the Mutant P450BM3 only control (black). New peaks are present at 17.72 min, 18.06 min 
and 19.70 min.  
 
Supplementary Figure 4-9 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing TPS24 
with Mutant P450BM3 at 17.72 min (red) with the library spectrum of pogostol (blue).  
 
 
Supplementary Figure 4-10 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPS24 with Mutant P450BM3 at 18.06 min (red) with the library spectrum of α-bisabolol (blue). 


















Scan 1214 (17.720 min): 3MUT.D\ data.ms (-1211) 1,4-Dimethyl-7-(prop-1-en-2-yl)decahydroazulen-4-olHead to Tail MF=850 RMF=870


































231 244 267 280 296 313 327 342 357 375 391 405 419 437 455 477 491
Scan 1247 (18.063 min): 3MUT.D\ data.ms (-1245) α-BisabololHead to Tail MF=914 RMF=945

































Supplementary Figure 4-11 Mass spectra from the extract of EPY300 expressing TPS24 with Mutant P450BM3 at 
19.70 min. 
GC-MS Data for TPS24 with dodecane overlay 
 
Supplementary Figure 4-12 TIC of dodecane from EPY300 expressing TPS24 with Mutant P450BM3 (black) 
overlayed with TIC of dodecane from EPY300 expressing TPS24 with wild-type P450BM3 (blue) and TIC of 
extract from the Mutant P450BM3 only control (red). Many new peaks are dodecane derivatives. New terpene 
peaks are present at 14.74 min, 15.68 min, 15.88 min, 17.72 min and 18.06 min. 
 
Supplementary Figure 4-13 Head-to-tail comparison of mass spectra from the dodecane overlay of EPY300 
expressing TPS24 with Mutant P450BM3 at 14.74 min (red) with the library spectrum of α-guaiene (blue). 
Scan 183 (14.741 min): TPS 24 Mut dodecane run 2.D\ data.ms (-186) α-GuaieneHead to Tail MF=939 RMF=951




































Supplementary Figure 4-14 Head-to-tail comparison of mass spectra from the dodecane overlay of EPY300 
expressing TPS24 with Mutant P450BM3 at 15.68 min (red) with the library spectrum of δ-guaiene (blue). 
 
Supplementary Figure 4-15 Mass spectra from the dodecane overlay of EPY300 expressing TPS24 with Mutant 
P450BM3 at 15.88 min. 
GC-MS Data for TPS26 
 
Supplementary Figure 4-16 TIC of extract from EPY300 expressing TPS26 with Mutant P450BM3 (blue) overlayed 
with TIC of extract from the Mutant P450BM3 only control (black). New peaks are present at 15.76 min, 16.10 min, 
17.33 min, 17.52 min and 17.70min.  
 
Scan 274 (15.688 min): TPS 24 Mut dodecane run 2.D\ data.ms (-277) Azulene, 1,2,3,5,6,7,8,8a-octahydro-1,4-dimethyl-7-(1-methylethenyl)-, [1S-(1α,7α,8aβ)]-Head to Tail MF=922 RMF=940

































(Text File) Scan 293 (15.886 min): TPS 24 Mut dodecane run 2.D\ data.ms (-295)
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Supplementary Figure 4-17 TIC of extract from EPY300 expressing TPS26 with Mutant P450BM3 (blue) overlayed 
with TIC of extract from the Mutant P450BM3 only control (black). A new peak is present at 22.20 min.  
 
Supplementary Figure 4-18 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPS26 with Mutant P450BM3 at 15.76min (red) with the library spectrum of δ-cadinene (blue). 
 
Supplementary Figure 4-19 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPS26 with Mutant P450BM3 at 17.33 min (red) with the library spectrum of di-epi-1,10-cubenol (blue). 
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T IC: 4M U T .D \d a ta .m s  (*)
Scan 1026 (15.764 min): 4MUT.D\ data.ms (-1021) Naphthalene, 1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-, (1S-cis)-Head to Tail MF=890 RMF=909


































Scan 1177 (17.335 min): 4MUT.D\ data.ms (-1172) Di-epi-1,10-cubenolHead to Tail MF=888 RMF=895





































Supplementary Figure 4-20 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPS26 with Mutant P450BM3 at 17.54 min (red) with the library spectrum of epicubenol (blue). 
 
Supplementary Figure 4-21 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPS26 with Mutant P450BM3 at 17.70 min (red) with the library spectrum of α-cadinol (blue). 
 
 
Supplementary Figure 4-22 Mass spectra from the extract of EPY300 expressing TPS26 with Mutant P450BM3 at 
16.10 min. 
 
Supplementary Figure 4-23 Mass spectra from the extract of EPY300 expressing TPS26 with Mutant P450BM3 at 
22.20 min.  
Scan 1197 (17.543 min): 4MUT.D\ data.ms (-1202) EpicubenolHead to Tail MF=906 RMF=919




































Scan 1212 (17.699 min): 4MUT.D\ data.ms (-1204) α-CadinolHead to Tail MF=890 RMF=903



























239 264 322 361 403 428 456 476
(Text File) Scan 1058 (16.097 min): 4MUT.D\ data.ms (-1054)














233 247 260 274 290 308 325 341 357 371 385 400 418 444 463 480 494
(Text File) Scan 1644 (22.194 min): 4MUT.D\ data.ms (-1640)
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GC-MS Data for TPS27 
 
Supplementary Figure 4-24 TIC of extract from EPY300 expressing TPS27 with Mutant P450BM3 (blue) overlayed 
with TIC of extract from the Mutant P450BM3 only control (black). New peaks are present at 14.20 min and 14.73 
min. 
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Supplementary Figure 4-25 TIC of extract from EPY300 expressing TPS27 with Mutant P450BM3 (blue) overlayed 
with TIC of extract from the Mutant P450BM3 only control (black). New peaks are present at 17.70 min, 19.82 min, 
20.02 min, 20.69 min and 21.38 min.  
 
Supplementary Figure 4-26 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPS27 with Mutant P450BM3 at 14.20min (red) with the library spectrum of β-caryophyllene (blue). 
 
Supplementary Figure 4-27 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPS27 with Mutant P450BM3 at 14.73 min (red) with the library spectrum of α-caryophyllene (humulene) (blue). 
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Scan 874 (14.182 min): 5MUT.D\ data.ms (-880) CaryophylleneHead to Tail MF=945 RMF=945



































Scan 926 (14.723 min): 5MUT.D\ data.ms (-929) HumuleneHead to Tail MF=946 RMF=949






































Supplementary Figure 4-28 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPS27 with Mutant P450BM3 at 17.70 min (red) with the library spectrum of α-cadinol (blue). 
 
Supplementary Figure 4-29 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPS27 with Mutant P450BM3 at 20.69 min (red) with the library spectrum of clovanediol (blue). 
 
Supplementary Figure 4-30 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPS27 with Mutant P450BM3 at 21.38 min (red) with the library spectrum of caryophyllene oxide (blue). 
 
 
Supplementary Figure 4-31 Mass spectra from the extract of EPY300 expressing TPS27 with Mutant P450BM3 at 
19.82 min. 
Scan 1212 (17.699 min): 5WT.D\ data.ms (-1206) α-CadinolHead to Tail MF=894 RMF=907

























Scan 1499 (20.686 min): 5MUT.D\ data.ms (-1495) (3S,3aS,6R,7R,9aS)-1,1,7-Trimethyldecahydro-3a,7-methanocyclopenta[8]annulene-3,6-diolHead to Tail MF=811 RMF=826
























259 278 298 318 336 357 376 414 453 481
Scan 1566 (21.383 min): 5MUT.D\ data.ms (-1563) Caryophyllene oxideHead to Tail MF=810 RMF=820























222 240 261 282 311 331 361 391 466 489
(Text File) Scan 1419 (19.853 min): 5MUT.D\ data.ms (-1411)















Supplementary Figure 4-32 Mass spectra from the extract of EPY300 expressing TPS27 with Mutant P450BM3 at 
20.02 min. 
 
GC-MS Data for Authentic Standards 
 
Supplementary Figure 4-33 TIC of α-caryophyllene standard (100ppm) 
 
Supplementary Figure 4-34 Mass spectrum of peak at 14.73 min of α-caryophyllene standard 
 
(Text File) Scan 1435 (20.020 min): 5MUT.D\ data.ms (-1444)
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Supplementary Figure 4-35 TIC of β-caryophyllene standard (100ppm) 
 
Supplementary Figure 4-36 Mass spectrum of peak at 14.20 min of β-caryophyllene standard 











TIC: B caryophyllene 100ppm.D\data.ms
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GS-MS Data for TPSY1 
 
Supplementary Figure 4-37 TIC of extract from EPY300 expressing TPSY1 with Mutant P450BM3 (blue) overlayed 
with TIC of extract from the Mutant P450BM3 only control (black). New peaks are present at 14.16 min, 14.33 min, 
14.58 min, 14.17 min, 15.15 min and 15.77 min.  
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Supplementary Figure 4-38 TIC of extract from EPY300 expressing TPSY1 with Mutant P450BM3 (blue) overlayed 
with TIC of extract from the Mutant P450BM3 only control (black). New peaks are present at 17.25 min, 17.52 min, 
17.70 min, 20.02 min and 20.47 min.  
 
Supplementary Figure 4-39 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY1with Mutant P450BM3 at 14.16 min (red) with the library spectrum of β-ylangene (blue). 
 
 
Supplementary Figure 4-40 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY1with Mutant P450BM3 at 14.33 min (red) with the library spectrum of β-cubebene(blue). 
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Scan 872 (14.161 min): 6MUT.D\ data.ms (-877) β-ylangeneHead to Tail MF=889 RMF=889































219 239 253 280 325 347 382 463
Scan 888 (14.328 min): 6MUT.D\ data.ms (-883) 1H-Cyclopenta[1,3]cyclopropa[1,2]benzene, octahydro-7-methyl-3-methylene-4-(1-methylethyl)-, [3aS-(3aα,3bβ,4β,7α,7aS*)]-Head to Tail MF=896 RMF=909






























Supplementary Figure 4-41 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY1with Mutant P450BM3 at 14.33 min (red) with the library spectrum of β-copaene (blue). 
 
Supplementary Figure 4-42 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY1with Mutant P450BM3 at 14.58 min (red) with the library spectrum of isogermacrene D (blue). 
 
Supplementary Figure 4-43 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY1with Mutant P450BM3 at 15.15  min (red) with the library spectrum of germacrene D (blue). 
 
Supplementary Figure 4-44 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY1with Mutant P450BM3 at 15.77  min (red) with the library spectrum of δ-cadinene (blue). 
Scan 888 (14.328 min): 6MUT.D\ data.ms (-883) β-copaeneHead to Tail MF=873 RMF=875



























235 253 278 301 327 378 405 448 480
Scan 925 (14.713 min): 6MUT.D\ data.ms (-930) (S,1Z,6Z)-8-Isopropyl-1-methyl-5-methylenecyclodeca-1,6-dieneHead to Tail MF=808 RMF=847























219 240 255 271 289 304 324 339 355 371 404 422 451 467 484
Scan 967 (15.150 min): 6MUT.D\ data.ms (-964) Germacrene DHead to Tail MF=897 RMF=930
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204
224 248 256 266 275 287 311 323 339 367 382 395 407 459 481
Scan 1025 (15.753 min): 6MUT.D\ data.ms (-1022) Naphthalene, 1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-, (1S-cis)-Head to Tail MF=825 RMF=878










































Supplementary Figure 4-45 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY1with Mutant P450BM3 at 17.25 min (red) with the library spectrum of juneol (blue). 
 
Supplementary Figure 4-46 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY1with Mutant P450BM3 at 17.52 min (red) with the library spectrum of α-cadinol (blue). 
 
Supplementary Figure 4-47 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY1with Mutant P450BM3 at 17.70 min (red) with the library spectrum of α-cadinol (blue). 
 
 
Scan 1168 (17.241 min): 6MUT.D\ data.ms (-1165) JunenolHead to Tail MF=912 RMF=918







































253 278 306 347 366 403
Scan 1195 (17.522 min): 6WT.D\ data.ms (-1192) α-CadinolHead to Tail MF=890 RMF=898
































245 277 286 325 341 396 487
Scan 1212 (17.699 min): 6WT.D\ data.ms (-1222) α-CadinolHead to Tail MF=931 RMF=940





































Supplementary Figure 4-48 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY1with Mutant P450BM3 at a) 20.02 min and b) 20.47 min (red) with the library spectrum of aromadendrene 
oxide (blue). 
 
Supplementary Figure 4-49 Mass spectra from the extract of EPY300 expressing TPS27 with Mutant P450BM3 at 
14.71 min. 
GC-MS Data for TPSY2 
 
(Text File) Scan 925 (14.713 min): 6WT.D\ data.ms (-930)
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Supplementary Figure 4-50 TIC of extract from EPY300 expressing TPSY2 with Mutant P450BM3 (blue) overlayed 
with TIC of extract from the Mutant P450BM3 only control (black). New peaks are present at 14.18 min, 14.73 min, 
15.75 min, 17.33 min and 17.54 min.  
 
Supplementary Figure 4-51 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY2 with Mutant P450BM3 at 14.18 min (red) with the library spectrum of β-caryophyllene (blue). 
 
Supplementary Figure 4-52 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY2 with Mutant P450BM3 at 14.73 min (red) with the library spectrum of α-caryophyllene (humulene) (blue). 
 
Supplementary Figure 4-53 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY2 with Mutant P450BM3 at 15.75 min (red) with the library spectrum of δ-cadinene (blue). 
 
Supplementary Figure 4-54 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY2 with Mutant P450BM3 at 17.33 min (red) with the library spectrum of di-epi-1,10-cubenol (blue). 
Scan 874 (14.182 min): 7WT.D\ data.ms (-870) CaryophylleneHead to Tail MF=931 RMF=931







































































Scan 926 (14.723 min): 7MUT.D\ data.ms (-922) HumuleneHead to Tail MF=935 RMF=940




































Scan 1025 (15.753 min): 7WT.D\ data.ms (-1022) Naphthalene, 1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-, (1S-cis)-Head to Tail MF=903 RMF=923





































214 241 252 264 277 296 308 320 331 340 386 401 430 445 454 463
Scan 1177 (17.335 min): 7WT.D\ data.ms (-1172) Di-epi-1,10-cubenolHead to Tail MF=905 RMF=910




































Supplementary Figure 4-55 Head-to-tail comparison of mass spectra from the extract of EPY300 expressing 
TPSY2 with Mutant P450BM3 at 17.54 min (red) with the library spectrum of epicubenol (blue). 
  
Scan 1196 (17.533 min): 7WT.D\ data.ms (-1202) EpicubenolHead to Tail MF=897 RMF=907







































Chapter 5 Molecular Modelling of Grapevine 
Cytochrome P450s  
Introduction 
Cytochrome P450s are a class of haemoproteins that are capable of oxygenating a wide 
variety of substrates and catalysing a range of interesting reactions, including 
hydroxylation, dehydrogenation, double-bond rearrangement, and carbon-bond cleavage 
(Manikandan & Nagini 2018). P450s primarily act as mono-oxygenases. They catalyse the 
cleavage of molecular dioxygen to insert a single oxygen atom onto a substrate, while the 
second oxygen atom is reduced to water. The reducing equivalents are provided by NADH 
or NADPH, which is facilitated by a redox partner that varies depending on the system. 
Overall, Cytochrome P450 systems catalyse the following reaction: 
RH + O2 + NAD(P)H +H+ → ROH + H2O + NAD(P)+ 
Cytochrome P450s are involved in the biosynthesis of many plant specialised metabolites, 
and are responsible for the production of a number of valuable plant compounds. For 
example, CYP71AV1 from Artemisia annua catalyses the three-step oxidation of amorpha-
4,11-diene to artemisinic acid, a precursor to the anti-malarial drug artemisinin (Ro et al. 
2006). Several P450s, including CYP71AV8 from Cichorium intybus, have been shown to 
convert (+)-valencene, a cheap and abundant sesquiterpene, to (+)-nootkatone, a natural 
compound that is valuable to the fragrance and flavouring industries (Cankar et al. 2011).  
As P450s are able to convert a broad range of substrates, they are valuable catalysts for 
biotechnology, and the identification and understanding of P450s has the potential to lead 
to the discovery of novel flavour and aroma molecules.  
The wine grape (Vitis vinifera) produces a number of P450-oxygenated metabolites that 
contribute to the flavour and aroma of wine, including monoterpenoids, flavonoids and 
sulphur compounds (Rapp & Mandery 1986; Yao et al. 2004). (-)-Rotundone, an 
oxygenated sesquiterpene, has been identified as a potent peppery aroma molecule 
(Wood et al. 2008). Rotundone is biosynthesised from the sesquiterpene α-guaiene in a 
two-step oxidation at the C2 position via rotundol (Figure 5-1) (Huang et al. 2014; Takase 
et al. 2016). Although this reaction can occur through aerial oxidations (Huang et al. 
2014), Takase et al. (2016) have identified a cytochrome P450, Vitis vinifera 
Sesquiterpene Oxidase 2 (VvSTO2), capable of adding a ketone moiety on C2 position of α-
guaiene backbone to produce (-)-rotundone. Rotundone has been known to be more 




Figure 5-1 Biosynthetic pathway of (-)-rotundone from α-guaiene 
Along with STO2, Takase et al. (2016) identified two other P450s, STO4 and STO6, in the 
same CYP71BE subfamily that accept α-guaiene as a substrate. STO4 and STO6 share 71% 
amino acid sequence identity with each other and 61-62% sequence identity with STO2. 
Despite their similarities, STO4 and STO6 are unable to convert α-guaiene to (2R)-
rotundol, (2S)-rotundol or (-)-rotundone. This suggests STO2 is unique within the 
CYP71BE subfamily. However, feeding α-guaiene to microsomal STO4 and STO6 proteins 
resulted in the formation of several, as yet unidentified products, including two products 
in common between the two P450s (Takase et al. 2016). Comparison of the structural and 
functional characteristics of STO2, STO4 and STO6 can lead to a better understanding of 
the substrate specificity and regio-specificity of STO2. As STO2 catalyses the formation 
of a valuable aroma molecule, understanding its mechanism could have implications 
for biotechnology and allow large-scale production of the molecule. Furthermore, 
investigating the roles of cytochrome P450s in grapevine could lead to the discovery 
of novel flavours and aromas so far unidentified in grapevine and wine. 
Here, comparative modelling and docking techniques were used to investigate the binding 
of α-guaiene within the binding sites of STO2, STO4 and STO6. Key residues that influence 
the binding orientation of α-guaiene and P450 reaction specificity were identified. Finally, 
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a yeast strain for the production of α-guaiene was created that can be used to test and 
analyse STO mutants.  
Results 
To investigate the mechanism and binding of P450s STO2, STO4 and STO6, α-guaiene was 
docked into a model structure of each enzyme. No crystal structures are available for 
STO2, STO4 or STO6 so it was necessary to use a homology modeling approach. Using 
protein-protein BLAST, Human Cytochrome P450 CYP17A1 (PDB accession 3RUK) was 
identified as a suitable template due to homology with the target P450s (27-28% for each 
of STO2, STO4 and STO6). Additionally, 3RUK is in complex with Abiraterone, a rigid, 
cyclic ligand, which may increase the speed and accuracy of docking α-guaiene, due to its 
similar structural properties. Models were evaluated using VADAR (Volume Area Dihedral 
Angle Reporter) (Willard et al. 2003). The Stereo/Packing and 3D Profile Quality indices 
are available in Supplementary Information (Supplementary Figure 5-1 and 
Supplementary Figure 5-2). 
Haem was docked into each of the grapevine P450 models using Autodock 4.2.6. 
Subsequently, α-guaiene was docked into each of the P450-haem complexes. As α-guaiene 
is relatively rigid, with only two rotatable bonds, the default docking parameters were 
sufficient for this application. Docking results were validated by repetition, and the results 
were found to be reproducible. The docking result conformation information is displayed 
in Table 5-1. The binding energy is calculated as the sum of the intermolecular energy and 
the torsional free-energy penalty.  
Table 5-1 Binding energy of the most stable conformations of α-guaiene docked into the binding sites of STO2, 
STO4 and STO6. Binding energy was calculated by Autodock as the sum of the intermolecular energy and the 
torsional free-energy penalty. 






Docking of α-guaiene into the model of STO2 shows the 5-membered ring in closest 
proximity to the porphyrin ring (Figure 5-2). C3 is nearest to the haem iron (3.0 Å). C2, 





Figure 5-2 Docking of α-guaiene into the model structure of VvSTO2 shows C3 in closest proximity to the haem 
iron (3.0 Å). C2, which is oxidised to form (-)-rotundone is positioned 4.2 Å from the haem iron. 
Docking of α-guaiene into the model of STO4 showed the substrate oriented such that C12 
and C13 were closest to the porphyrin ring (3.4 Å and 4.0 Å) (Figure 5-3).  
 
Figure 5-3 Docking of α-guaiene into the model structure of VvSTO4 shows a very different conformation to that 




Figure 5-4 Docking of α-guaiene into the model structure of VvSTO6 gives two distinct conformations. A) α-
guaiene is positioned with C12 and C13 in closest proximity to the haem iron, at 5.0 and 5.2 Å. B) α-guaiene is 
positioned with C9 and C15 in closest proximity to the porphyrin ring (3.4 and 5.0 Å respectively). 
Docking of α-guaiene into the model of STO6 produced two different stable conformations 
(Figure 5-4). In the first conformation, α-guaiene is positioned in a similar orientation to 
that of the STO4 binding, with C12 and C13 closest to the porphyrin ring (5.0 Å and 5.2 Å) 
(Figure 5-4A). In the second conformation, α-guaiene is positioned such that the 7-
membered ring is closest to the porphyrin ring with C9 and C15 in closest proximity to 
the haem iron (3.4 and 5.0 Å respectively, Figure 5-4B). 
As these docking results show a clear difference in the positioning of α-guaiene within the 
binding site, it was hypothesised that key residues in the P450 binding pocket would alter 
the orientation of α-guaiene within the active site and, subsequently, the regioselectivity 
of the reaction.  Multiple sequence alignment of the grapevine P450s was performed using 
ClustalW (Figure 5-5). Residues within 4 Å of the docked α-guaiene substrate were 
identified using PyMol. From this, three residues in particular were identified as being 





Figure 5-5 Amino acid sequence alignment of VvSTO4, VvSTO6 and VvSTO2. Multiple sequence alignment was 
performed by ClustalW and visualised using BioEdit. Similar amino acids are highlighted in blue. Amino acids 
within 4 Å of the docked substrate are highlighted in purple. Differing amino acids within 4 Å of the binding sites 




Table 5-2 Amino acids within 4 Å of the docked α-guaiene substrate. Docking was performed using Autodock 
4.2.6 and measurements performed using PyMol. Dissimilar amino acids are highlighted in green.  









D302 D305 E306 
A306 
  
T310 T307 S308 
V371 F367 F368 







R486 L483 L484 
T487 A484 A485 
 
It is proposed that mutation of V371, R486 and T487 may alter the regioselectivity of the 
α-guaiene oxidation reaction by STO2 and lead to the formation of novel products. 
Furthermore, mutation of STO4 and STO6 at their corresponding amino acid positions 
may enable these enzymes to convert α-guaiene to rotundone.  
In order to test this, it is necessary to obtain a source of α-guaiene. α-Guaiene is not 
available commercially, although it can be extracted from agarwood (Wood et al. 2008). 
An alternative method is to construct a yeast strain for the production of α-guaiene that 
can subsequently be used to test different P450 mutants in vivo.  
To produce α-guaiene in yeast, EPY300 was transformed with pESC-Leu containing a 
codon-optimised synthetic gene VvTPS24 (Supplementary Information), a grapevine 
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sesquiterpene synthase that produces α-guaiene as one of its major products (Drew et al. 
2016). The culture was analysed by GC-MS for sesquiterpene products. The presence of α-
guaiene was confirmed by comparing the sample mass spectrum to a standard mass-




Figure 5-6 GC-MS data from EPY300 pESC-LEU2d-TPS24 strain. A) Overlay of total ion chromatograms (TIC) 
from control strain (black) and experimental strain (blue). B) Mass spectrum of peak 1. C) Mass spectrum of α-
guaiene, from NIST library. 
Discussion 
Modelling the binding of the α-guaiene substrate with the different V. vinifera P450s 
provides insight into the reaction specificity and the possible resulting products. Since 
experimental crystal structures of STO2, STO4 and STO6 are not available, the most 
reliable tool for obtaining structural data on these targets is to use computational 
modelling based on the three-dimensional structure of a homologous protein (Suresh 
Kumar, Thomas & Poornima 2018). Human Cytochrome P450 CYP17A1 (3RUK) was 
chosen as a template, and shares a sequence homology of 27-28% with the grapevine 
P450s. Sequence homology is not the only consideration when choosing a template; the 
functional context of the structure must also be taken into account (Schmidt, Bergner & 
Schwede 2014). Naegleria fowleri CYP51 (PDB accession 5TL8) was also identified as a 
suitable template based on sequence homology, but it is in complex with posaconazole, a 
large, flexible, linear ligand. Alternatively, 3RUK is in complex with abiraterone, a smaller 
and more rigid compound that bears greater structural resemblance to α-guaiene (Figure 
5-7). Therefore, using 3RUK as a template is more likely to give fast and accurate results 
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when the P450 models are used to dock α-guaiene. Although the sequence homology 
between the STOs and 3RUK is relatively low, the structural folding pattern of distantly 
related P450s is surprisingly conserved (Poulos & Johnson 2015; Schmidt, Bergner & 
Schwede 2014), so the 3RUK crystal structure can still be a reliable template.  However, 
the crystal structure is limited to 2.6 Å resolution, which will further limit the resolution 
of the model.  
 
Figure 5-7 The structures of posaconazole, the 5TL8 ligand, and abiraterone, the 3RUK ligand. Abiraterone has a 
smaller and more rigid structure that bears greater resemblance to α-guaiene, so 3RUK was chosen as a more 
appropriate template for homology modelling.  
Although computational modelling of proteins is limited by the resolution of the template 
and the similarity of the target and template proteins, it has been shown to be an 
appropriate and reliable technique for the study of P450 structure and function. There are 
many examples in the literature where P450 modelling has provided insights to 
structure/function relationships that are supported by experimental mutation studies 
(Eichler et al. 2016; Luirink et al. 2018; Nikolaus et al. 2017). Therefore, computational 
modelling of P450s is a reliable method that can be used to gain insights into enzyme 
function and provide initial directions for experimental work. The STO models were 
assessed using VADAR and the results show reasonable quality indices. The 3D profile 
index assesses the local environment, packing and hydrophobic energy for the given 
structure (Willard et al. 2003). The majority of residues have quality indices which fall 
within the typical range of 5-8, and problem areas (scores below 4) are not located 
around the active site (Supplementary Figure 5-1). The stereo/packing index assesses 
backbone angles, and the presence of packing defects such as atomic overlap or large gaps 
(Willard et al. 2003).  The majority of residues have stereo/packing indices above the 
benchmark of 6, although some defects are present (Supplementary Figure 5-2). 
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Nevertheless, the quality indices show that in general, local protein structure and folds 
are spatially reasonable, confirming that these models are appropriate for docking and 
binding site analysis. 
Docking α-guaiene into the substrate recognition sites of each of the three STOs may 
improve understanding of the product specificity of these P450s. The docking binding 
energy can be used to compare the stability of the docked conformations and assess the 
most stable conformation (Table 5-1). The binding energy for all three STOs was negative, 
indicating binding of α-guaiene to the proteins is energetically favourable. Docking α-
guaiene with STO2 and STO6 resulted in similar binding energies, but docking α-guaiene 
into STO4 gives a less favourable binding energy, indicating that STO4 may have lower 
binding affinity for α-guaiene. There is little difference in stability between the two 
different STO6 docked conformations, suggesting both binding orientations would readily 
arise.  
Within the model structure of STO2, α-guaiene is positioned such that C2, which is 
selectively oxidised by STO2 to form (-)-rotundone, is positioned 4.2 Å from the haem iron 
(Figure 5-2). This distance is similar to iron-substrate distances reported for co-
crystallised structures of other P450-substrate complexes. For example, P450cam and 
P450eryF have been observed  to bind fatty acids with a distance of 4.2-4.8 Å between the 
atom that is hydroxylated and the porphyrin iron (Li & Poulos 1997). The docking model 
shows that C2 is positioned within ideal distance of the catalytic iron atom, explaining the 
formation of rotundone by STO2. It should be noted that C3 is modelled to be closest to 
the haem iron, at a distance of 3.0 Å. However, this distance is relatively short, and not 
within the typical catalytic distance of P450s. C3 may bind in this position but avoid 
oxidation due to steric hindrance, or the measured distance could be incorrect due to the 
limitations of the model.  
Despite the limitations of the model, the modelled binding orientation of α-guaiene within 
the binding pocket of STO2 shows a clear contrast to the STO4 and STO6 docking models. 
The distinctly different orientations of the substrate within the binding site explain why 
STO4 and STO6 do not produce rotundone. α-Guaiene docks within the STO4 binding 
pocket such that C12 and C13 are in closest proximity to the haem iron (Figure 5-3), so it 
is expected that oxidation would occur at these sites. Docking of α-guaiene into the model 
structure of VvSTO6 gives two distinct conformations (Figure 5-4): one where α-guaiene 
is positioned with C12 and C13 in closest proximity to the haem iron, and another with α-
guaiene positioned with C9 and C15 in closest proximity to the porphyrin ring. In all three 
of these binding orientations, C2 is positioned further away from the haem iron and is 
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therefore not readily oxidised by STO4 and STO6, hence STO4 and STO6 do not form (-)-
rotundone or (-)-rotundol.  
Previously, STO4 and STO6 have been observed to oxidise α-guaiene to form several, 
currently unidentified, compounds, including two compounds produced by both enzymes 
(Takase et al. 2016). The similarities between the orientation of α-guaiene within the 
STO4 binding site (Figure 5-3) and the first orientation of α-guaiene within the STO6 
binding site (Figure 5-4A) may explain the two products in common, as in both these 
orientations C12 and C13 are in closest proximity to the haem iron.  In the STO6 model, 
C12 and C13 are positioned at a greater distance from the haem iron (5.0 and 5.2 Å), but 
P450 oxidation has still been shown to occur at this distance. X-ray crystallography and 
NMR data have shown P450BM3 binds substrates at a distance of 7.5-7.9 Å from the 
porphyrin ring (Li & Poulos 1997), so the distance observed between the STO6 haem iron 
and the α-guaiene substrate is not catalytically unreasonable.  Both STO4 and STO6 would 
be expected to oxidise α-guaiene at C12 and C13 and form the potential products shown 
in Figure 5-8. While the masses of these products are consistent with the GC-MS data 
obtained by Takase et al. (2016) for the unidentified peaks, further confirmation such as 
direct comparison of the GC-MS with a standard or NMR analysis is needed to accurately 
identify the products.  
 
Figure 5-8 Potential products formed through the oxidation of α-guaiene by STO4 and STO6 
Previous studies have shown that mutations in the substrate recognition site of plant 
P450s can alter the substrate selectivity, product specificity and regiospecificity of the 
oxidation reaction (Kahn et al. 2001; Komori et al. 2013; Takahashi et al. 2005). Since 
STO2, STO4 and STO6 share high homology (60-71%), it was hypothesised that key 
residues within the substrate binding sites could account for the difference in products 
formed by these enzymes. Residues within 4 Å of the docked substrate were compared 
(Table 5-2). While STO4 and STO6 share highly similar binding residues, there are three 
key differences identified within the STO2 binding site. It is expected that mutation of 
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these residues would alter the binding of α-guaiene and the products formed. The change 
from valine at position 371 to phenylalanine would introduce steric effects that change 
the shape of the binding pocket, and introduce a new hydrogen bond donor. Mutation of 
the arginine in position 486 to leucine would disrupt electrostatic interactions with the 
positively-charged residue. Finally, replacing threonine with alanine at position 487 
would introduce another hydrogen bond donor and further change the shape of the 
binding site and the interactions with the substrate. However, experimental site-specific 
mutation studies are required to confirm these assumptions.  
In order to conduct site-specific mutation studies, it is necessary to provide a source of α-
guaiene to feed to the target enzymes. α-Guaiene can be extracted from agarwood (Wood 
et al. 2008) or synthesised from guaiol (Takase et al. 2016). Previously, in vitro enzyme 
assays have been performed by the addition of α-guaiene to microsomal proteins (Takase 
et al. 2016). An alternative approach is to perform in vivo assays using a yeast strain 
engineered to produce α-guaiene. Mutant P450s could be expressed directly by the 
engineered strain, allowing rapid analysis of products and straightforward genetic 
manipulation and screening of mutants.  
The strain EPY300 has been engineered to overproduce FPP, the sesquiterpene precursor 
(Ro et al. 2006). This is achieved by upregulation of the mevalonate pathway and the 
repression of squalene synthesis. EPY300 has been previously used for the de novo 
synthesis of plant sesquiterpenes and oxygenated sesquiterpenoids with typical yields in 
the range of up to 10 mg (Nguyen, MacNevin & Ro 2012). Several plant sesquiterpene 
synthases that produce α-guaiene have been identified. Faraldos et al. (2010) discovered 
a patchoulol synthase from Pogostemon cablin that produces α-guaiene as 26% of a 
mixture of products. Two sesquiterpene synthases were identified from cultured cells of 
Aquilaria, one that produced α-guaiene as its major product (44%) and another that 
produced α-guaiene as a minor product (18%) (Kumeta & Ito 2010). A particular allele of 
the VvTPS24 gene has been shown to encode the sesquiterpene synthase VvGuaS that 
produces α-guaiene as its major product (44%) (Drew et al. 2016). VvTPS24 was chosen 
for expression in EPY300 as it produces a high proportion of α-guaiene and is naturally 
involved in (-)-rotundone biosynthesis in grape. Furthermore, the use of a grapevine 
sesquiterpene synthase means the system has the potential to be used to identify novel 
oxygenated sesquiterpenoids found in grapevine that could be produced from VvTPS24 
minor products. VvTPS24 was expressed in EPY300 and the resulting strain was shown to 
produce α-guaiene in culture (Figure 5-6). P450 mutants could be tested using this system 
by transforming the yeast strain with a vector containing the P450 and its redox partner 
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and analysing the culture for novel products using GC-MS. Product identification may be 
performed by comparing the GC-MS data against a library or by purification of the 
product and NMR.   
 
Conclusions 
This study has provided preliminary insight into the mechanism and binding of three 
grapevine P450s, including STO2, which is responsible for the production of rotundone, a 
valuable peppery aroma in wine. Modelling suggests that differences in the binding 
orientation of α-guaiene within the P450 binding sites are responsible for the variation in 
products formed by STO2, STO4 and STO6. Three key residues have been identified within 
the STO2 binding site that may affect product specificity, but experimental site-specific 
mutation studies are needed to confirm these hypotheses. A platform for conducting these 
experiments has been created by constructing a yeast strain capable of producing α-
guaiene.  
P450s are versatile and valuable catalysts that are capable of producing a large range of 
compounds in nature. Understanding the mechanism and binding of P450s in grapevine 
may assist in the discovery of novel flavours and aromas. Furthermore, identification of 
key residues within the binding sites of P450s allows targeted mutation and has the 
potential to lead to the formation of new products. Understanding key residues within the 
substrate recognition sites may assist in identification of novel P450 alleles within plant 
genomes and the discovery of unique metabolites.  
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Supplementary Figure 5-1 3D Profile Quality Index of grapevine cytochrome P450 models. Quality indices were 




Supplementary Figure 5-2 Stereo/Packing Quality Index of grapevine cytochrome P450 models. Quality indices 
were calculated by VADAR.  
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Chapter 6 Thesis Summary 
 
The focus of this work was to use microbial biosynthesis to investigate two classes of 
grapevine specialised metabolites: tartaric acid (TA) and its biosynthetic intermediates, 
and sesquiterpenoids, in particular the pepper aroma rotundone. 
The first aim was to produce L-idonate, the substrate for the rate-limiting reaction in TA 
biosynthesis, via the microbial biotransformation of 2-keto-L-gulonate. Two potential Vitis 
vinifera 2-ketogulonate reductases (2KGRs) were identified using bioinformatics based on 
homology to two specific 2KGRs identified in Aspergillus niger. In vitro characterisation of 
these proteins showed they were capable of reducing 2-keto-L-gulonate, but no evidence 
was found for the formation of L-idonate. Substrate specificity tests suggest the enzymes 
possess broad-spectrum, low-level reductase activity, although their primary substrate 
may not have been tested. It is unlikely that these enzymes are involved in the 
biosynthesis of TA from ascorbic acid. To fully characterise these enzymes, their activity 
could be tested against a wider range of substrates, and reaction conditions, including 
temperature, enzyme concentration, substrate concentration and cofactor concentration, 
could be optimised. Enzyme activity may also be tested using NADP+/NADPH as cofactor, 
and assays could be performed to investigate the affinity of each enzyme for each cofactor. 
Since these enzymes are unlikely to play a role in the biosynthesis of TA, there is 
increased evidence for the involvement of the previously identified Vv2KGR in this 
pathway. However, in planta evidence is required to directly confirm the role of this 
enzyme in TA synthesis.  
As the two putative 2KGRs identified did not produce high levels of L-idonate, instead the 
previously identified Vv2KGR was used to investigate the viability of a whole-cell 
biotransformation system for the production of L-idonate. Although the 2KGR activity of 
Vv2KGR has previously been confirmed in vitro, cell permeability proved a significant 
challenge, and E. coli cells expressing Vv2KGR were not able to convert 2-keto-L-gulonate 
to L-idonate in the whole-cell system. Future research may investigate other methods of 
increasing cell permeability, such as treatment with solvents or detergents, or 
bioengineering. Alternative host organisms may also be investigated, such as a gram-
positive bacterium or eukaryotic organism. Alternatively, the bioconversion of 2-keto-L-
gulonate may be achieved in vitro with purified soluble or resin-bound enzyme. However, 
this could be significantly expensive, as exogenous cofactor would need to be supplied, 
and Vv2KGR prefers NADPH over NADH (Jia 2015). Using the A. niger enzyme GluC, an 
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NADH-dependent 2KGR, may be a more economical option for cell-free 
biotransformation. 
Chapters 4 and 5 describe experiments in which the biosynthesis and microbial synthesis 
of sesquiterpenoids were investigated. Six V. vinifera sesquiterpene synthases were 
expressed in EPY300, a yeast strain engineered to overproduce farnesyl pyrophosphate 
(FPP), the sesquiterpene precursor.  Co-expression of these sesquiterpene synthases with 
a promiscuous cytochrome P450 monooxygenase in EPY300 enabled the microbial 
synthesis of complex sesquiterpenoids from a simple sugar feedstock. The six 
sesquiterpene synthases collectively produced a large number of structurally diverse 
sesquiterpenoids. A total of seventeen unique compounds were confidently identified. A 
number of uncharacterised compounds were also found in the cell extract samples. To 
identify these compounds, yeast cultures could be scaled up and the extracts purified by 
chromatography to allow the collection of several milligrams of purified product for NMR 
analysis. This could lead to the identification of novel sesquiterpenoids, which are not 
only relevant to winemaking but also to the flavour and aroma industries. A number of the 
identified compounds also possessed previously identified bioactivity, which may serve as 
a marketing platform for wines containing these compounds. This work may serve as a 
useful platform for the future identification of sesquiterpenoids in grapevine and their 
contributions to the flavour, aroma, and health benefits of wine. 
Chapter 5 focussed on the sesquiterpenoid rotundone, which is responsible for the 
‘peppery’ character of some wines (Wood et al. 2008). Rotundone is formed by oxidation 
of the sesquiterpene hydrocarbon α-guaiene, which is catalysed by Sesquiterpene Oxidase 
2 (STO2) in V. vinifera. Two other, closely related P450s, STO4 and STO6 are also capable 
of utilising α-guaiene as substrate but do not produce rotundone (Takase et al. 2016). 
Computational homology modelling of STO2, STO4 and STO6 revealed that differences in 
the binding orientation of α-guaiene within the P450 active site are responsible for the 
differences in products formed by these three enzymes. It was hypothesised that 
rotundone is formed by STO2 due to the positioning of the C3 carbon of α-guaiene in close 
proximity to the STO2 haem. Three key residues within the STO2 binding site were 
identified that may affect product specificity, and by altering these residues it may be 
possible to produce novel sesquiterpenoids. Experimental site-specific mutation studies 
are needed to confirm these hypotheses. To do this, a yeast strain capable of producing α-
guaiene was constructed. This strain can be used to express STO mutants, allowing in vivo 
production of sesquiterpenoids and rapid screening and analysis of mutant enzymes. New 
products may be isolated by extraction of large-scale culture followed by purification of 
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the extraction mixture. The products can then be identified by NMR spectroscopy. 
Mutagenesis studies will increase understanding of the mechanism and binding of these 
P450s in grapevine, and may assist in the discovery of novel aromas or flavours. 
Understanding the role of key residues within the P450 active site may facilitate the 
identification of novel P450 alleles within plant genomes and the discovery of unique 
metabolites. 
Specialised metabolites play many roles that allow plants to gain evolutionary advantages, 
but many are also useful to humans. Plant specialised metabolites have been used by 
humans for millennia as fragrances, flavours and drugs. Specialised metabolites in 
grapevine are of particular importance to the wine industry, as the composition of 
specialised metabolites confer unique flavours and characteristics to the wine. 
Furthermore, there has been a recent growth in interest in the potential health benefits of 
consuming certain compounds in wine.  
Microbial biosynthesis has been shown to be a useful method for the investigation of 
these metabolites as it allows facile, rapid and stereoselective synthesis of natural 
compounds. Although the biocatalysis of L-idonate requires further optimisation, the 
microbial biosynthesis of sesquiterpenoids using EPY300 is well-established and has 
facilitated the rapid identification of grapevine sesquiterpenoids. The investigation of 
these specialised metabolites has provided insights into the biosynthesis of tartaric acid 
and sesquiterpenoids in grapevine, and may assist in the identification and production of 
novel wine aromas and flavours, and the development of varietals selected for the 
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